Notices. Advance Notice of Intent

32,571 words·~148 min read·/register/2007/10/17/07-5121

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 3710-AJ-M DEPARTMENT OF ENERGY Office of Environmental Management; Advance Notice of Intent To Prepare an Environmental Impact Statement for Area IV of the Santa Susana Field Laboratory and Public Involvement Activities AGENCY: Department of Energy. ACTION: Advance Notice of Intent. SUMMARY: The U.S. Department of Energy

(DOE)is providing an Advance Notice of its Intent

(ANOI)to prepare an Environmental Impact Statement

(EIS)for remediation of Area IV of the Santa Susana Field Laboratory (SSFL). DOE is preparing the EIS in response to a May 2, 2007, decision by the U.S. District Court of Northern California that a 2003 DOE decision to prepare a Finding of No Significant Impact (FONSI) and conduct remediation of Area IV on the basis of an environmental assessment, rather than prepare an EIS, violated the National Environmental Policy Act (NEPA). DOE is also requesting early comments from the public and other stakeholders on the scope of the EIS and issues to be considered in EIS analysis. To facilitate collaboration on these EIS issues, DOE also is announcing plans for public involvement activities to be held this fall, to provide information to its stakeholders and to receive comments from them. DOE is issuing this ANOI, pursuant to 10 CFR 1021.311(b), in order to inform and request early comments and assistance from Federal and State agencies, State and local governments, natural resource trustees, the general public, and other interested parties on the appropriate scope of the EIS, possible environmental issues, and the potential environmental impacts related to DOE's proposed activities for Area IV. Following the issuance of this ANOI, DOE intends to collect updated information that it will incorporate into the EIS analysis. DOE will conduct community and regulator interviews through November 2007. These public involvement opportunities will focus on consultation with the public about the process for EIS scoping, the development of the range of reasonable alternatives to be analyzed in the EIS, and related public concerns about the remediation. If, based on community input, DOE decides to hold a public meeting, DOE will notify the community through local media. Early comments on the scope of the EIS and issues to be considered are due by December 14, 2007. Though DOE will attempt to consider comments received after this date, it will only be able to do so to the extent practicable. DOE plans to issue a Notice of Intent

(NOI)for this EIS in the spring of calendar year 2008. ADDRESSES: Please direct requests to be notified of interviews or a public meeting, comments on the scope of the EIS, and questions concerning the proposed project to: Stephanie Jennings, NEPA Document Manager, Office of Site Support and Small Projects (EM-3.2), U.S. Department of Energy, Energy Technology Engineering Center, P.O. Box 10300, Canoga Park, CA 91309, telephone: 818-466-8162, fax: 818-466-8730, or e-mail to: *Stephanie.Jennings@em.doe.gov* (use “ANOI comments” for the subject). FOR FURTHER INFORMATION CONTACT: To request further information about this EIS or about the public involvement activities, or to be placed on the EIS distribution list, use any of the methods listed under ADDRESSES above. For general information concerning the DOE NEPA process, contact Carol Borgstrom, Director, Office of NEPA Policy and Compliance (GC-20), U.S. Department of Energy, 1000 Independence Avenue, SW., Washington, DC 20585-0119, e-mail to: *AskNEPA@hq.doe.gov,* telephone: 202-586-4600, leave a message at 1-800-472-2756, or fax: 202-586-7031. This Advance Notice of Intent

(ANOI)will be available on the Internet at: *http://www.eh.doe.gov/NEPA.* Further information about Area IV and the Energy Technology Engineering Center

(ETEC)can be found at *http://apps.em.doe.gov/etec/.* SUPPLEMENTARY INFORMATION: Background Santa Susana Field Laboratory (SSFL), located on approximately 2,850 acres in the hills between Chatsworth and Simi Valley, CA, was developed as a remote site to test rocket engines and conduct nuclear research. The Atomics International Unit of Rockwell International's Canoga Park-based Rocketdyne Division began testing in 1947, and conducted an estimated 17,000 open-air rocket tests in support of the space program. In 1996, Rockwell International sold its aerospace and defense business, including the SSFL to The Boeing Company (Boeing). SSFL is divided in four administrative areas—Area I, Area II, Area III, and Area IV—along with two buffer zones. Area I is about 713 acres, of which 671 acres is owned and operated by Boeing and 42 acres is owned by the National Aeronautics and Space Administration

(NASA)and operated for it by Boeing. Area II, about 410 acres, is owned by NASA and operated for it by Boeing. Area III, about 114 acres, is owned and operated by Boeing. Area IV, about 290 acres, is owned by Boeing, which operates it for DOE. Boeing also owns a contiguous buffer zone of 1143 acres to the south and a contiguous buffer zone of 182 acres to the north. Starting in the mid-1950s, the Atomic Energy Commission (AEC), a predecessor agency of DOE, funded nuclear energy research on a 90-acre parcel of Area IV leased from Rocketdyne. The Energy Technology and Engineering Center

(ETEC)was established by the AEC on this parcel in the early 1960s as a “center of excellence” for liquid metals technology. The AEC built a small nuclear power plant to deliver energy to the commercial grid at the ETEC. Research also included testing of nuclear powered systems, for example, using liquid metals for space vehicles and a sodium coolant medium in 10 small reactors. All reactor operations ended in 1980 and nuclear research work was completed in 1988. Cleanup of ETEC began in the 1960s and was performed in an ongoing manner as unnecessary facilities were decommissioned when there was no longer a use for them. DOE continues to lease the 90 acre parcel in Area IV from Boeing. In March 2003, DOE issued an Environmental Assessment (EA), *Environmental Assessment for Cleanup and Closure of the Energy Technology Engineering Center,* DOE/EA-1345. Based on the results of the EA, DOE determined that an EIS was not required and issued a FONSI in March 2003. DOE is now preparing an SSFL Area IV EIS in response to the U.S. District Court of Northern California's May 2, 2007, ruling in the case *Natural Resources Defense Council* v. *Department of Energy Slip Op.* WL2349288 (N.D. Cal. Aug.15, 2007), which held that DOE's decision to issue a FONSI and conduct cleanup and closure on the basis of DOE/EA-1345 was in violation of NEPA. The Court ordered DOE to prepare an EIS for Area IV in accordance with NEPA. The Court further permanently enjoined the DOE from transferring ownership or possession, or otherwise relinquishing control over any portion of Area IV, until DOE completes the EIS and issues a Record of Decision pursuant to NEPA. In addition, the Court retained jurisdiction until it is satisfied that the DOE has met its legal obligations as they relate to the remediation of Area IV. Because of the Court's decision, DOE suspended the physical demolition and removal activities for the remaining facilities at ETEC except for those activities necessary to maintain the site in a safe and stable configuration. DOE has discontinued planned decontamination and decommission activities, but is continuing surveillance, maintenance, and environmental monitoring work, including soil and groundwater characterization required under the State of California Department of Toxic Substances Control

(DTSC)regulations, while it prepares the EIS. In August 2007, DTSC issued a Consent Order to DOE, NASA and Boeing under its Resource Conservation and Recovery Act

(RCRA)authority. This Order requires cleanup of all chemically contaminated soils at SSFL by 2017 or earlier, provides the option for DTSC to require more work to be conducted offsite of Area IV to assess air, soil and water contamination, and requires the preparation of an Environmental Impact Report, pursuant to the California Environmental Quality Act. Early Public Involvement and Related Activities DOE is issuing this ANOI, pursuant to 10 CFR 1021.311(b), in order to inform and request early comments and assistance from Federal and State agencies, State and local governments, natural resource trustees, the general public, and other interested parties on the scope of the EIS, proposed environmental issues, and the potential environmental impacts related to DOE's potential activities at this site. Following the issuance of this ANOI, DOE intends to collect updated information that it will incorporate into the EIS analysis. Purpose and Need for Agency Action DOE needs to complete remediation of Area IV to comply with applicable regulations and allow for an evaluation of the range of reasonable alternatives. The remediation will include cleanup of radiological and hazardous contaminants both onsite and offsite of Area IV and maintain surface and groundwater protection in accordance with applicable requirements. Proposed Action and EIS Scope DOE's proposed action includes demolition of radiological facilities, demolition of most support buildings, cleanup of solid waste management units, groundwater remediation, mitigation measures, and disposal of all waste offsite at approved facilities. The EIS will evaluate the remediation of Area IV under current action plans and alternatives to them. The EIS will characterize environmental media, analyze the environmental impact of decontaminating and decommissioning or dismantling government buildings and structures, and analyzing environmental restoration activities for environmental contamination associated with DOE's activities. Waste management activities to be analyzed include operation, maintenance, and closure of RCRA-permitted facilities. The facilities that are to be included in the EIS include former radiological facilities, former sodium facilities, and administrative facilities. The EIS will consider the effects of possible contamination by non-radiological toxic or otherwise hazardous materials and address multiple exposures (chemical and radiological), as well as exposures to multiple radionuclides. The EIS will consider the suitability of Area IV for a range of future land uses, and assess possible radiological contamination of groundwater. The EIS may be used in the preparation of the Environmental Impact Report that is required by the DTSC Consent Order. Preliminary Identification of Issues DOE is requesting input on the best methods to obtain accurate information on radiological and hazardous contamination in Area IV. It is also seeking input from stakeholders to resolve current and potential issues associated with RCRA constituents and to determine the extent of groundwater contamination both onsite and offsite of Area IV. Preliminary Environmental Impacts for Analysis DOE has tentatively identified the following environmental impacts for analysis in the Area IV EIS. This list is presented to facilitate early comment during the public involvement activities on the scope of the EIS. • Potential impacts to the general population, workers, and the environment from radiological and non-radiological releases. • Potential impacts to soils, air, surface water quality, and groundwater quality. • Potential transportation impacts from the shipment of radiological and non-radiological wastes to disposal sites. • Potential impacts from postulated accidents. • Potential impacts from intentional destructive acts. • Potential disproportionately high and adverse effects on low-income and minority populations (environmental justice). • Land use impacts. • Socioeconomic impacts. • Ecological resources (endangered species and wetlands). • Cultural and paleontological resources. • Compliance with applicable Federal, state and local requirements. • Long-term site suitability, including erosion and seismicity. • Cumulative impacts from contamination both onsite and offsite of Area IV. • Mitigation measures to avoid or mitigate potentially significant environmental impacts. Invitation To Comment DOE invites the public to provide early assistance in identifying the scope of the Area IV EIS, alternatives, environmental issues to consider, and environmental impacts to analyze through the early public involvement process. DOE will consider public comments and other relevant information in developing the NOI. Comments should be provided by the DATES and to the ADDRESSES above. EIS Process DOE plans to issue the NOI in the spring of calendar year 2008, which will be followed by a public scoping period to assist in further defining the scope of the EIS and identifying significant issues to be addressed. The NOI will propose the range of reasonable alternatives for remediation of the Area IV site. After the NOI is issued, DOE will conduct public scoping meetings. During the scoping period, the dates and locations of meetings will be announced in the local media. DOE will announce the availability of the Draft EIS in the **Federal Register** and other media and provide Federal and State agencies, State and local governments, natural resource trustees, the general public, and other interested parties with an opportunity to submit comments. DOE will also hold at least one public hearing in order to gather comments on the sufficiency of the Draft EIS once it is published. These comments will be considered and addressed in the Final EIS. DOE will issue a Record of Decision no sooner than 30 days after EPA's notice of availability of the Final EIS. Issued in Washington, DC, on October 10, 2007. Ines R. Triay, (Acting) Assistant Secretary for Environmental Management. [FR Doc. E7-20449 Filed 10-16-07; 8:45 am] BILLING CODE 6450-01-P DEPARTMENT OF ENERGY Office of Science; Climate Change Science Program Product Development Advisory Committee AGENCY: Department of Energy. ACTION: Notice of Open Teleconference Meeting. SUMMARY: This notice announces a teleconference meeting of the Climate Change Science Program Product Development Advisory Committee. Federal Advisory Committee Act (Pub. L. 92-463, 86 Stat. 770) requires that public notice of these meetings be announced in the **Federal Register** . DATES: Monday, October 29, 2007, 1 p.m. to 4 p.m. E.D.T. ADDRESSES: Participants may call Ms. Karen Carlson-Brown at

(301)903-3338 to receive a call-in number by October 25, 2007. Public participation is welcomed; however, the number of teleconference lines is limited and available on a first come basis. FOR FURTHER INFORMATION CONTACT: Dr. Anjuli S. Bamzai (301-903-0294; *anjuli.bamzai@science.doe.gov* ) Designated Federal Officer, Climate Change Science Program Product Development Advisory Committee, U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Climate Change Research Division, SC-23.3/Germantown Building, 1000 Independence Avenue, SW., Washington, DC 20585-1290. The most current information concerning this meeting can be found on the Web site: *http://www.science.doe.gov/ober/cpdac/announcement.html* . SUPPLEMENTARY INFORMATION: *Purpose of the Meeting:* To continue discussions on drafting the Climate Change Science Program

(CCSP)Synthesis and Assessment Product related to climate modeling. This activity is being conducted at the request of the Department of Energy, in accordance with the CCSP Guidelines for Producing the CCSP Synthesis and Assessment Products. *Tentative Agenda:* • Discussion on how public review comments have been addressed by the Synthesis and Assessment Product

(SAP)3.1 author team in the current version of the report. • Discussion on how comments from CPDAC members have been addressed by the SAP 3.1 author team in the current version of the report. • Motion by Chair of CPDAC to seek concurrence on the draft SAP 3.1 • Public comment (10 minute rule). *Public Participation:* The teleconference meeting is open to the public. If you would like to file a written statement with the Committee, you may do so either before or after the meeting. If you would like to make oral statements regarding any of the items on the agenda, you should contact Anjuli Bamzai at the address or telephone number listed above. Reasonable provisions will be made to include the scheduled oral statements on the agenda. The Chairperson of the Committee will conduct the meeting to facilitate the orderly conduct of business. Public comment will follow the 10-minute rule. This notice is being published less than 15 days before the date of the meeting due to programmatic issues. *Minutes:* The minutes of this meeting will be available for public review at *http://www.science.doe.gov/ober/CPDACminutes_presentations.html.* Issued in Washington, DC on October 11, 2007. Rachel Samuel, Deputy Committee Management Officer. [FR Doc. E7-20491 Filed 10-16-07; 8:45 am] BILLING CODE 6450-01-P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Docket No. QF08-1-000] Albemarle Hospital—Elizabeth City, NC; Notice of Filing of Notice of Self-Certification of Qualifying Status of a Cogeneration Facility October 10, 2007. Take notice that on October 1, 2007, Albemarle Hospital located at 1144 N. Road St., Elizabeth City, NC 27906 filed with the Federal Energy Regulatory Commission a notice of self-certification of a facility as a qualifying cogeneration facility pursuant to 18 CFR 292.207(a) of the Commission's regulations. This qualifying cogeneration facility consists of a 550 kW packaged diesel engine generator set operating on #2 fuel oil. The package is set on a concrete pad. The unit is self-contained, including all necessary switchgear and controls. The electricity is generated at 480 V, 3 phase, 60 Hz. The facility is located at 1144 N. Road St., Elizabeth City, NC 27906. This qualifying facility interconnects with the City of Elizabeth's electric distribution system. The facility will provide standby power and occasionally supplementary power to Albermerle Hospital. A notice of self-certification does not institute a proceeding regarding qualifying facility status; a notice of self-certification provides notice that the entity making the filing has determined the Facility meets the applicable criteria to be a qualifying facility. Any person seeking to challenge such qualifying facility status may do so by filing a motion pursuant to 18 CFR 292.207(d)(iii). This filing is accessible on-line at *http://www.ferc.gov,* using the ``eLibrary'' link and is available for review in the Commission's Public Reference Room in Washington, DC. There is an ``eSubscription'' link on the Web site that enables subscribers to receive e-mail notification when a document is added to a subscribed docket(s). For assistance with any FERC Online service, please e-mail *FERCOnlineSupport@ferc.gov,* or call

(866)208-3676 (toll free). For TTY, call

(202)502-8659. Kimberly D. Bose, Secretary. [FR Doc. E7-20394 Filed 10-16-07; 8:45 am] BILLING CODE 6717-01-P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Docket No. CP08-1-000] MarkWest New Mexico, L.P.; Notice of Request Under Blanket Authorization October 10, 2007. Take notice that on October 1, 2007, MarkWest New Mexico, L.P. (MarkWest), 1515 Arapahoe Street, Tower 2, Suite 700, Denver, Colorado 80202-2126, filed in Docket No. CP08-1-000, a prior notice request pursuant to sections 157.205 and 157.210 of the Federal Energy Regulatory Commission's regulations under the Natural Gas Act for authorization to construct, own, operate, and maintain approximately 3.16 miles of new 16-inch diameter pipeline and appurtenant facilities on its existing natural gas transmission mainline, located in Lea County, New Mexico, all as more fully set forth in the application, which is on file with the Commission and open to public inspection. The filing may also be viewed on the web at *http://www.ferc.gov* using the “eLibrary” link. Enter the docket number excluding the last three digits in the docket number field to access the document. For assistance, contact FERC at *FERCOnlineSupport@ferc.gov* or call toll-free,

(886)208-3676 or TYY,

(202)502-8659. MarkWest states that its existing natural gas transmission system consists of approximately five miles of 10- and 12-inch diameter pipeline facilities, which provide firm transportation service to two power plants owned by Southwestern Public Service Company. MarkWest proposes to construct approximately 1.45 miles of 16-inch diameter pipeline parallel to and looping the existing 10- and 12-inch diameter mainline and approximately 1.71 miles of additional 16-inch diameter pipeline to provide firm transportation service to a third power plant that is to be constructed by Lea Power Partners, LLC, located in Lea County, New Mexico. MarkWest asserts that the expansion facilities will increase the maximum capacity of MarkWest's system from 166 MMcf/d to 276 MMcf/d and will include the construction of a new interconnection with Northern Natural Gas Company. MarkWest estimates the cost of construction to be $3.2 million. Any questions regarding the application should be directed to Danny Dollar, MarkWest New Mexico, L.P., 1515 Arapahoe Street, Tower 2, Suite 700, Denver, Colorado 80202-2126, or call at (1-800) 852-9226. Any person or the Commission's Staff may, within 60 days after the issuance of the instant notice by the Commission, file pursuant to Rule 214 of the Commission's Procedural Rules (18 CFR 385.214) a motion to intervene or notice of intervention and, pursuant to section 157.205 of the Commission's Regulations under the Natural Gas Act

(NGA)(18 CFR 157.205) a protest to the request. If no protest is filed within the time allowed therefore, the proposed activity shall be deemed to be authorized effective the day after the time allowed for protest. If a protest is filed and not withdrawn within 30 days after the time allowed for filing a protest, the instant request shall be treated as an application for authorization pursuant to Section 7 of the NGA. The Commission strongly encourages electronic filings of comments, protests, and interventions via the Internet in lieu of paper. See 18 CFR 385.2001(a)(1)(iii) and the instructions on the Commission's Web site ( *www.ferc.gov* ) under the “e-Filing” link. Kimberly D. Bose, Secretary. [FR Doc. E7-20395 Filed 10-16-07; 8:45 am] BILLING CODE 6717-01-P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Docket No. TX07-2-000] Nevada Power Company; Notice of Filing October 10, 2007. Take notice that on September 28, 2007, pursuant to section 211 of the Federal Power Act (FPA), Nevada Power Company (Nevada Power), on behalf of Calpine Corporation, filed an application requesting the Federal Energy Regulatory Commission order Nevada Power to provide transmission services to Calpine Corporation under the terms of a specific 400 MW transmission service agreement. This order is necessary to preserve the tax-exempt status of Nevada Power's local furnishing bonds. Nevada Power agrees to waive its right to a request for service under section 213(a) of the FPA and to the issuance of a proposed order under section 212(c) of the FPA. Any person desiring to intervene or to protest this filing must file in accordance with Rules 211 and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211, 385.214). Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a notice of intervention or motion to intervene, as appropriate. Such notices, motions, or protests must be filed on or before the comment date. On or before the comment date, it is not necessary to serve motions to intervene or protests on persons other than the Applicant. The Commission encourages electronic submission of protests and interventions in lieu of paper using the “eFiling” link at *http://www.ferc.gov* . Persons unable to file electronically should submit an original and 14 copies of the protest or intervention to the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426. This filing is accessible on-line at *http://www.ferc.gov* , using the “eLibrary” link and is available for review in the Commission's Public Reference Room in Washington, DC. There is an “eSubscription” link on the Web site that enables subscribers to receive e-mail notification when a document is added to a subscribed docket(s). For assistance with any FERC Online service, please e-mail *FERCOnlineSupport@ferc.gov* , or call

(866)208-3676 (toll free). For TTY, call

(202)502-8659. *Comment Date:* 5 p.m. Eastern Time on October 29, 2007. Kimberly D. Bose, Secretary. [FR Doc. E7-20393 Filed 10-16-07; 8:45 am] BILLING CODE 6717-01-P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission Combined Notice of Filings #1 October 10, 2007. Take notice that the Commission received the following electric corporate filings: *Docket Numbers:* EC07-136-000. *Applicants:* NRG Energy, Inc.; Long Beach Generation LLC; Long Beach Peakers LLC. *Description:* NRG Energy, Inc *et al.* , submit an application for approval of the disposition of jurisdictional facilities pursuant to section 203 of the Federal Power Act and requests for waivers. *Filed Date:* 09/27/2007. *Accession Number:* 20071001-0039. *Comment Date:* 5 p.m. Eastern Time on Thursday, October 18, 2007. Take notice that the Commission received the following exempt wholesale generator filings: *Docket Numbers:* EG08-2-000. *Applicants:* Arlington Wind Power Project LLC. *Description:* Notice of self-certification of exempt wholesale generator status of Arlington Wind Power Project LLC. *Filed Date:* 10/09/2007. *Accession Number:* 20071008-5024. *Comment Date:* 5 p.m. Eastern Time on Tuesday, October 30, 2007. *Take notice that the Commission received the following electric rate filings:* *Docket Numbers:* ER00-1053-020. *Applicants:* Maine Public Service Company. *Description:* Maine Public Service Company informs FERC of the status of negotiations regarding its 6/15/07 informational filing setting forth the changed open access tariff changes effective 6/1/07. *Filed Date:* 10/05/2007. *Accession Number:* 20071009-0175. *Comment Date:* 5 p.m. Eastern Time on Friday, October 26, 2007. *Docket Numbers:* ER02-1173-004; ER02-1336-004; ER06-1265-001. *Applicants:* Front Range Power Company, LLC; Vandolah Power Company, LLC; Orlando CoGen Limited, L.P. *Description:* Front Range Power Company, LLC *et al.* submits its Notice of Non-Material Change in Status in connection with the acquisition by USB Americas etc. pursuant to Order 652. *Filed Date:* 10/04/2007. *Accession Number:* 20071009-0095. *Comment Date:* 5 p.m. Eastern Time on Thursday, October 25, 2007. *Docket Numbers:* ER05-644-007. *Applicants:* PSEG Energy Resources & Trade, LLC. *Description:* Informational filing of PSEG Energy Resources & Trade LLC listing planned Project Investments and projected Project Investment costs for CY 2008 with respect to PSEG Fossil LLC's generating units. *Filed Date:* 10/01/2007. *Accession Number:* 20071001-5094. *Comment Date:* 5 p.m. Eastern Time on Monday, October 22, 2007. *Docket Numbers:* ER05-1119-004. *Applicants:* Doswell Limited Partnership. *Description:* PJM and Doswell Limited Partnership, jointly, submitted an Electric Refund Report pursuant to the July 5, 2007, FERC order. *Filed Date:* 10/09/2007. *Accession Number:* 20071008-5022. *Comment Date:* 5 p.m. Eastern Time on Tuesday, October 30, 2007. *Docket Numbers:* ER06-615-014. *Applicants:* California Independent System Operator Corporation *Description:* California Independent System Operator Corporation submits proposed revisions to its Market Redesign and Technology Upgrade to comply with the Paragraph 175 of the June 25 Order. *Filed Date:* 10/05/2007. *Accession Number:* 20071010-0041. *Comment Date:* 5 p.m. Eastern Time on Friday, October 26, 2007. *Docket Numbers:* ER06-1178-003; ER06-1179-003 *Applicants:* SEMASS Partnership *Description:* Change in status of SEMASS Partnership. *Filed Date:* 10/09/2007. *Accession Number:* 20071009-5071. *Comment Date:* 5 p.m. Eastern Time on Tuesday, October 30, 2007. *Docket Numbers:* ER06-1260-001. *Applicants:* Northern Indiana Public Service Company. *Description:* Northern Indiana Public Service Company submits an application for expansion of prior limited waivers of codes of conduct with Whiting Clean Energy Inc. *Filed Date:* 10/03/2007. *Accession Number:* 20071005-0017. *Comment Date:* 5 p.m. Eastern Time on Wednesday, October 24, 2007. *Docket Numbers:* ER06-1399-003. *Applicants:* Sunbury Generation LP. *Description:* Sunbury Generation L.P. submits a Notice of Change in Status. *Filed Date:* 10/04/2007. *Accession Number:* 20071009-0164. *Comment Date:* 5 p.m. Eastern Time on Thursday, October 25, 2007. *Docket Numbers:* ER07-1102-003 *Applicants:* PJM Interconnection, L.L.C. *Description:* PJM Interconnection, LLC responds to the notice of deficiency issued by FERC on 9/5/07. *Filed Date:* 10/05/2007. *Accession Number:* 20071009-0165. *Comment Date:* 5 p.m. Eastern Time on Friday, October 26, 2007. *Docket Numbers:* ER07-1144-001. *Applicants:* American Transmission Company LLC. *Description:* American Transmission Company, LLC and the Midwest Independent Transmission System Operator, Inc submit a revised Energy Markets Tariff sheets in compliance with FERC's 9/7/07 Order. *Filed Date:* 10/05/2007. *Accession Number:* 20071010-0042. *Comment Date:* 5 p.m. Eastern Time on Friday, October 26, 2007. *Docket Numbers:* ER07-1249-002. *Applicants:* Lockport Energy Associates, L.P. *Description:* Lockport Energy Associates L.P. requests waiver of the sixty day prior notice requirement to allow its tariff to become effective on 10/9/07. *Filed Date:* 10/09/2007. *Accession Number:* 20071010-0044. *Comment Date:* 5 p.m. Eastern Time on Tuesday, October 30, 2007. *Docket Numbers:* ER07-1250-001. *Applicants:* PowerGrid Systems, Inc. *Description:* PowerGrid Systems, Inc. submits a letter of clarification in response to FERC's request for revisions and original Sheet 2 to FERC Electric Tariff, Original Volume 1 to reflect the requirements of Order 697. *Filed Date:* 09/28/2007. *Accession Number:* 20071003-0022. *Comment Date:* 5 p.m. Eastern Time on Friday, October 19, 2007. *Docket Numbers:* ER07-1276-000. *Applicants:* Niagara Mohawk Power Corporation. *Description:* Motion to Withdraw Filing of Service Agreement No. 1156 of Niagara Mohawk Power Corporation. *Filed Date:* 10/05/2007. *Accession Number:* 20071005-5070. *Comment Date:* 5 p.m. Eastern Time on Wednesday, October 17, 2007. *Docket Numbers:* ER07-1331-001. *Applicants:* Indianapolis Power & Light Company. *Description:* Indianapolis Power & Light Company submits revisions to IPL Rate Schedule FERC 21. *Filed Date:* 10/09/2007. *Accession Number:* 20071010-0045. *Comment Date:* 5 p.m. Eastern Time on Tuesday, October 30, 2007. *Docket Numbers:* ER07-1356-001. *Applicants:* BE Alabama LLC. *Description:* BE Alabama LLC submits corrected Revised Substitute Original Sheet 1 and 2 to FERC Electric Tariff, First Revised Volume 1 to replace the 9/7/07 filing of a notice of succession, effective date of 11/6/07. *Filed Date:* 10/04/2007. *Accession Number:* 20071009-0163. *Comment Date:* 5 p.m. Eastern Time on Thursday, October 25, 2007. *Docket Numbers:* ER07-1358-001. *Applicants:* BE Louisiana LLC. *Description:* BE Louisiana, LLC submits Revised Substitute Original Sheet to FERC Electric Tariff, First Revised Volume 1 to replace the tariff sheets submitted on 9/7/07 with notice of succession etc. pursuant to Order 697. *Filed Date:* 10/04/2007. *Accession Number:* 20071009-0162. *Comment Date:* 5 p.m. Eastern Time on Thursday, October 25, 2007. *Docket Numbers:* ER07-1386-001. *Applicants:* Tatanka Wind Power, LLC. *Description:* Amendment to application of Tatanka Wind Power LLC for order accepting market-based rate tariff, granting authorizations and blanket authority, and waiving certain requirements. *Filed Date:* 10/05/2007. *Accession Number:* 20071010-0043. *Comment Date:* 5 p.m. Eastern Time on Monday, October 15, 2007. *Docket Numbers:* ER08-17-000. *Applicants:* Southern California Edison Company. *Description:* Southern California Edison Co. submits an amended Manzana Wind Project Engineering Design, and Procurement Letter Agreement for Early Interconnection Facilities with PPM Energy, Inc. *Filed Date:* 10/03/2007. *Accession Number:* 20071004-0141. *Comment Date:* 5 p.m. Eastern Time on Wednesday, October 24, 2007. *Docket Numbers:* ER08-18-000. *Applicants:* PacifiCorp. *Description:* PacifiCorp submits a Notice of Termination of their Rate Schedule 418 with Public Utility District 1 of Clark County, WA. *Filed Date:* 10/03/2007. *Accession Number:* 20071004-0142. *Comment Date:* 5 p.m. Eastern Time on Wednesday, October 24, 2007. *Docket Numbers:* ER08-19-000. *Applicants:* Energy Algorithms, LLC. *Description:* Energy Algorithms, LLC submits petition for acceptance of FERC Electric Rate Schedule 1. *Filed Date:* 10/03/2007. *Accession Number:* 20071004-0143. *Comment Date:* 5 p.m. Eastern Time on Wednesday, October 24, 2007. *Docket Numbers:* ER08-22-000. *Applicants:* PJM Interconnection, L.L.C. *Description:* PJM Interconnection, LLC submits several revisions to Schedule 2 of the Open Access Transmission Tariff. *Filed Date:* 10/04/2007. *Accession Number:* 20071005-0006. *Comment Date:* 5 p.m. Eastern Time on Thursday, October 25, 2007. *Docket Numbers:* ER08-23-000. *Applicants:* Massie Power LLC. *Description:* Massie Power, LLC submits their FERC Electric Rate Schedule 1 under which they will engage in wholesale electric power and energy transactions as marketer. *Filed Date:* 10/04/2007. *Accession Number:* 20071005-0005. *Comment Date:* 5 p.m. Eastern Time on Thursday, October 25, 2007. *Docket Numbers:* ER08-25-000; ER08-26-000. *Applicants:* Ocean State Power; Ocean State Power II. *Description:* Ocean State Power and Ocean State Power II submits their application for an order accepting rates, OSP FERC Electric Tariff, Original Volume 1 *et al.* *Filed Date:* 10/04/2007. *Accession Number:* 20071005-0003. *Comment Date:* 5 p.m. Eastern Time on Thursday, October 25, 2007. *Docket Numbers:* ER08-27-000. *Applicants:* New York State Electric & Gas Corporation. *Description:* New York State Electric & Gas Corporation submits Original Service Agreement 1159 with Lockport Energy Associates, LP under the Service Agreement. *Filed Date:* 10/04/2007. *Accession Number:* 20071009-0168. *Comment Date:* 5 p.m. Eastern Time on Thursday, October 25, 2007. *Docket Numbers:* ER08-28-000. *Applicants:* Puget Sound Energy, Inc. *Description:* Puget Sound Energy, Inc submits revisions to Original Sheet 22A *et al.* to FERC Electric Tariff, Eighth Revised Volume 7. *Filed Date:* 10/05/2007. *Accession Number:* 20071009-0167. *Comment Date:* 5 p.m. Eastern Time on Friday, October 26, 2007. *Docket Numbers:* ER08-29-000. *Applicants:* Pacific Gas and Electric Company. *Description:* Pacific Gas and Electric Company submits filing and acceptance amendments to two interconnection Agreements with Northern California Power Agency. *Filed Date:* 10/05/2007. *Accession Number:* 20071009-0166. *Comment Date:* 5 p.m. Eastern Time on Friday, October 26, 2007. *Docket Numbers:* ER08-30-000. *Applicants:* Wisconsin Public Service Corporation. *Description:* Wisconsin Public Service Corp submits a contract with Forward Energy LLC and on 10/9/07 submit the execution pages of the Integration Contract between itself and Forward Energy, LLC. *Filed Date:* 10/05/2007; 10/09/2007. *Accession Number:* 20071010-0039; 20071010-0047. *Comment Date:* 5 p.m. Eastern Time on Friday, October 26, 2007. *Docket Numbers:* ER08-31-000. *Applicants:* Entergy Services, Inc. *Description:* Entergy Services Inc, on behalf of Entergy Gulf States Inc *et al.* submits an agreement under Service Schedule MSS-4 of the Entergy System Agreement. *Filed Date:* 10/05/2007. *Accession Number:* 20071010-0040. *Comment Date:* 5 p.m. Eastern Time on Friday, October 26, 2007. Take notice that the Commission received the following foreign utility company status filings: *Docket Numbers:* FC08-1-000. *Applicants:* Macquarie Bank Limited. *Description:* Macquarie Notice of Self-Certification of Foreign Utility Company Status. *Filed Date:* 10/10/2007. *Accession Number:* 20071009-5131. *Comment Date:* 5 p.m. Eastern Time on Wednesday, October 31, 2007. Take notice that the Commission received the following open access transmission tariff filings: *Docket Numbers:* OA08-2-000. *Applicants:* Kansas City Power & Light Company. *Description:* Request for Waiver of Kansas City Power & Light Company. *Filed Date:* 10/09/2007. *Accession Number:* 20071009-5048. *Comment Date:* 5 p.m. Eastern Time on Tuesday, October 30, 2007. Any person desiring to intervene or to protest in any of the above proceedings must file in accordance with Rules 211 and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 385.214) on or before 5 p.m. Eastern time on the specified comment date. It is not necessary to separately intervene again in a subdocket related to a compliance filing if you have previously intervened in the same docket. Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Anyone filing a motion to intervene or protest must serve a copy of that document on the Applicant. In reference to filings initiating a new proceeding, interventions or protests submitted on or before the comment deadline need not be served on persons other than the Applicant. The Commission encourages electronic submission of protests and interventions in lieu of paper, using the FERC Online links at *http://www.ferc.gov* . To facilitate electronic service, persons with Internet access who will eFile a document and/or be listed as a contact for an intervenor must create and validate an eRegistration account using the eRegistration link. Select the eFiling link to log on and submit the intervention or protests. Persons unable to file electronically should submit an original and 14 copies of the intervention or protest to the Federal Energy Regulatory Commission, 888 First St., NE., Washington, DC 20426. The filings in the above proceedings are accessible in the Commission's eLibrary system by clicking on the appropriate link in the above list. They are also available for review in the Commission's Public Reference Room in Washington, DC. There is an eSubscription link on the Web site that enables subscribers to receive e-mail notification when a document is added to a subscribed dockets(s). For assistance with any FERC Online service, please e-mail *FERCOnlineSupport@ferc.gov* or call

(866)208-3676 (toll free). For TTY, call

(202)502-8659. Nathaniel J. Davis, Sr., Acting Deputy Secretary. [FR Doc. E7-20391 Filed 10-16-07; 8:45 am] BILLING CODE 6717-01-P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission Sunshine Act Meeting Notice October 11, 2007. The following notice of meeting is published pursuant to section 3(a) of the government in the Sunshine Act (Pub. L. 94-409), 5 U.S.C. 552b: Agency Holding Meeting: Federal Energy Regulatory Commission. Date And Time: October 18, 2007, 10 a.m. Place: Room 2C, 888 First Street, NE., Washington, DC 20426. Status: Open. Matters To Be Considered: Agenda. * **Note** —Items listed on the agenda may be deleted without further notice. Contact Person For More Information: Kimberly D. Bose, Secretary, Telephone

(202)502-8400. For a recorded message listing items struck from or added to the meeting, call

(202)502-8627. This is a list of matters to be considered by the Commission. It does not include a listing of all documents relevant to the items on the agenda. All public documents, however, may be viewed on line at the Commission's Web site at *http://www.ferc.gov* using the eLibrary link, or may be examined in the Commission's Public Reference Room. 923rd—Meeting Regular Meeting [October 18, 2007, 10 a.m.] Item No. Docket No. Company ADMINISTRATIVE A-1 AD02-1-000 Agency Administrative Matters. A-2 AD02-7-000 Customer Matters, Reliability, Security and Market Operations. A-3 AD06-3-000 Energy Market Update. ELECTRIC E-1 EL00-95-164 San Diego Gas & Electric Company (Bonneville Power Administration v. Federal Energy Regulatory Commission). E-2 RR07-16-000 North American Electric Reliability Corporation. E-3 EC07-39-000, EC07-39-001, EC07-39-002 The Goldman Sachs Group, Inc. E-4 EC07-45-000, EC07-45-001, EC07-45-002 Morgan Stanley. E-5 EC07-99-000 Great Plains Energy Incorporated. EL07-75-000 Kansas City Power & Light Company Aquila, Inc., Black Hills Corporation. E-6 EC06-166-000, EC06-166-001 Legg Mason, Inc. E-7 ER07-478-001, ER07-478-003 Midwest Independent Transmission System Operator, Inc. E-8 ER07-478-002 Midwest Independent Transmission System Operator, Inc. E-9 RR06-1-010 North American Electric Reliability Corporation. E-10 OMITTED E-11 ER07-1186-000 PJM Interconnection, L.L.C. E-12 ER07-1251-000, ER07-1251-001 Northern Maine Independent System Administrator, Inc. E-13 ER07-1245-000 ISO New England Inc. and New England Power Pool. E-14 RC07-1-000 Mosaic Fertilizer, LLC. RC07-2-000 City of Tampa, Florida. E-15 ER07-995-000, ER07-995-001 New York Independent System Operator, Inc. E-16 ER07-546-002 ISO New England Inc. ER07-546-003, ER07-547-001 New England Power Pool. E-17 EL07-31-000 DTE Pontiac North LLC. E-18 OMITTED E-19 ER07-805-001, ER07-805-002, ER07-1304-000 California Independent System Operator Corporation. E-20 ER97-4166-024, ER96-780-017, EL04-124-005 Southern Company Energy Marketing, L.P. and Southern Company Services, Inc. E-21 ER07-748-001 New York Independent System Operator, Inc. E-22 ER07-541-002 Entergy Services, Inc. E-23 ER05-231-005, ER05-231-006 PSEG Power Connecticut, LLC. E-24 ER05-163-005, ER05-163-006 Milford Power Company, LLC. E-25 EL05-76-002 The United Illuminating Company v. Dominion Energy Marketing, Inc. E-26 ER07-525-002 Entergy Services, Inc. E-27 ER06-1218-005 PJM Interconnection, L.L.C. E-28 OMITTED MISCELLANEOUS M-1 OMITTED GAS G-1 OMITTED G-2 RP07-500-000, RP07-500-001, RP07-500-002 Columbia Gulf Transmission Company. G-3 RP07-509-000, RP07-509-001, RP07-509-002 Columbia Gas Transmission Corporation. G-4 RP07-179-002, RP07-179-001 Gulf South Pipeline Company, LP. G-5 RP07-473-000 National Energy and Trade LP v. Texas Gas Transmission LLC and Gulf South Pipeline LP. HYDRO H-1 P-11437-022 Hydro Matrix Limited Partnership. H-2 P-12484-002 Metro Hydroelectric Company, LLC. H-3 P-9401-066 Mt. Hope Waterpower Project, L.L.P. H-4 P-12911-001, P-12911-002 Electric Plant Board of the City of Paducah, Kentucky H-5 P-1494-300 Grand River Dam Authority. H-6 P-233-105 Pacific Gas and Electric Company. CERTIFICATES C-1 OMITTED C-2 CP07-88-000 Egan Hub Storage, LLC. C-3 CP05-357-006 Cheniere Creole Trail Pipeline, L.P. CP07-426-000 Cheniere Sabine Pass Pipeline, L.P. C-4 CP07-395-000 Wyoming Interstate Company, Ltd. C-5 RM07-17-000 Revisions to Landowner Notification and Blanket Certificate Regulations. Kimberly D. Bose, Secretary. A free Web cast of this event is available through *http://www.ferc.gov.* Anyone with Internet access who desires to view this event can do so by navigating to *www.ferc.gov's* Calendar of Events and locating this event in the Calendar. The event will contain a link to its Web cast. The Capitol Connection provides technical support for the free Web casts. It also offers access to this event via television in the DC area and via phone bridge for a fee. If you have any questions, visit *http://www.CapitolConnection.org* or contact Danelle Springer or David Reininger at 703-993-3100. Immediately following the conclusion of the Commission Meeting, a press briefing will be held in the Commission Meeting Room. Members of the public may view this briefing in the designated overflow room. This statement is intended to notify the public that the press briefings that follow Commission meetings may now be viewed remotely at Commission headquarters, but will not be telecast through the Capitol Connection service. [FR Doc. E7-20392 Filed 10-16-07; 8:45 am] BILLING CODE 6717-01-P ENVIRONMENTAL PROTECTION AGENCY [FRL-8483-5] Agency Information Collection Activities OMB Responses AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: This document announces the Office of Management and Budget's

(OMB)responses to Agency Clearance requests, in compliance with the Paperwork Reduction Act (44 U.S.C. 3501 *et. seq* ). An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control numbers for EPA's regulations are listed in 40 CFR part 9 and 48 CFR chapter 15. FOR FURTHER INFORMATION CONTACT: Rick Westlund

(202)566-1682, or e-mail at *westlund.rick@epa.gov* and please refer to the appropriate EPA Information Collection Request

(ICR)Number. SUPPLEMENTARY INFORMATION: OMB Responses to Agency Clearance Requests OMB Approvals EPA ICR Number 1713.06; Federal Operating Permit Regulations (Renewal); in 40 CFR part 71; was approved 09/12/2007; OMB Number 2060-0336; expires 09/30/2010. EPA ICR Number 1587.07; State Operating Permit Regulations (Renewal); in 40 CFR part 70; was approved 09/12/2007; OMB Number 2060-0243; expires 09/30/2010. EPA ICR Number 1967.03; NESHAP for Stationary Combustion Turbines (Renewal); in 40 CFR part 63, subpart YYYY; was approved 09/19/2007; OMB Number 2060-0540; expires 09/30/2010. EPA ICR Number 2243.04; Procedures for Implementing the National Environmental Policy Act

(NEPA)and Assessing Environmental Effects Abroad of EPA Actions (Final Rule); was approved 09/20/2007; OMB Number 2020-0033; expires 08/31/2010. EPA ICR Number 0783.53; Motor Vehicle Emissions and Fuel Economy Compliance: Light Duty Vehicles, Light Duty Trucks, and Highway Motorcycles (Final Rule); in 40 CFR part 600, 40 CFR parts 85 and 86, 40 CFR 86.1845-86.1886, 40 CFR 86.412-86.486, and 40 CFR part 85.1901-85.1908; was approved 09/27/2007; OMB Number 2060-0104; expires 11/30/2008. EPA ICR Number 1857.04; NOX Budget Trading Program to Reduce the Regional Transport of Ozone (Renewal); in 40 CFR 51.121, 40 CFR 51.122, 40 CFR 75, subpart H; was approved 09/27/2007; OMB Number 2060-0445; expires 09/30/2010. EPA ICR Number 1593.07; Air Emission Standards for Tanks, Surface Impoundments and Containers (Renewal); in 40 CFR part 265, subpart CC, 40 CFR part 264, subpart CC; was approved 10/04/2007; OMB Number 2060-0318; expires 10/31/2010. EPA ICR Number 2256.02; NESHAP for Acrylic/Modacrylic Fibers Production, Carbon Black Production, Chemical Manufacturing: Chromium Compounds, Flexible Polyurethane Foam Production/Fabrication, Lead Acid Battery Manufacturing, Wood Preserving (Final Rule); in 40 CFR part 63, subpart PPPPPP; 40 CFR part 63, subpart QQQQQQ; 40 CFR part 63, subpart LLLLLL; 40 CFR part 63, subpart MMMMMM; 40 CFR part 63, subpart NNNNNN; 40 CFR part 63, subpart OOOOOO; was approved 10/04/2007; OMB Number 2060-0598; expires 10/31/2010. EPA ICR Number 1844.03; NESHAP for Petroleum Refineries, Catalytic Cracking, Reforming and Sulfur Units (Renewal); in 40 CFR part 63, subpart UUU; was approved 10/08/2007; OMB Number 2060-0554; expires 10/31/2010. EPA ICR Number 1896.07; Disinfectants/Disinifection Byproducts, Chemical and Radionuclides; Short Term Regulatory Revisions and Clarifications to the National Primary Drinking Water Regulations for Lead and Copper (Final Rule); in 40 CFR part 141 and 40 CFR part 142; was approved 10/10/2007; OMB Number 2040-0204; expires 06/30/2008. Short Term Approval EPA ICR Number 1560.07; National Water Quality Inventory Reports (Clean Water Act Sections 305(b), 303(d), 314(a) and 106(e)); in 40 CFR part 130; short term extension was approved by OMB on 09/24/2007; OMB Number 2040-0071; expires 12/31/2007. Comment Filed EPA ICR Number 2251.01; Control of Emissions from Nonroad Spark-Ignition Engines and Equipment (Proposed Rule); OMB filed comments on 10/04/2007. Withdrawn EPA ICR Number 2225.01; Assessment of EPA Partnership Programs was withdrawn by Agency on 09/14/2007. Dated: October 9, 2007. Sara Hisel-McCoy, Acting Director, Collection Strategies Division. [FR Doc. E7-20439 Filed 10-16-07; 8:45 am] BILLING CODE 6560-50-P ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPP-2006-0860; FRL-8483-4] Agency Information Collection Activities; Submission to OMB for Review and Approval; Comment Request; Plant-Incorporated Protectants; CBI Substantiation and Adverse Effects Reporting; EPA ICR No. 1693.05, OMB Control No. 2070-0142 AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: In compliance with the Paperwork Reduction Act (44 U.S.C. 3501 *et seq.* ), this document announces that an Information Collection Request

(ICR)has been forwarded to the Office of Management and Budget

(OMB)for review and approval. This is a request to renew an existing approved collection. The ICR, which is abstracted below, describes the nature of the information collection and its estimated burden and cost. DATES: Additional comments may be submitted on or before November 16, 2007. ADDRESSES: Submit your comments, referencing Docket ID No. EPA-HQ-OPP-2006-0860, to

(1)EPA online using *www.regulations.gov* (our preferred method), by e-mail to *opp.ncic@epa.gov* , or by mail to: OPP Regulatory Public Docket (7502P), Office of Pesticide Programs (OPP), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001, and

(2)OMB by mail to: Office of Information and Regulatory Affairs, Office of Management and Budget (OMB), Attention: Desk Officer for EPA, 725 17th Street, NW., Washington, DC 20503. FOR FURTHER INFORMATION CONTACT: Joseph Hogue, Field and External Affairs Division, Office of Pesticide Programs, 7506P, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460; telephone number: 703-308-9072; fax number: 703-305-5884; e-mail address: *hogue.joe@epa.gov.* SUPPLEMENTARY INFORMATION: EPA has submitted the following ICR to OMB for review and approval according to the procedures prescribed in 5 CFR 1320.12. On March 14, 2007 (72 FR 11862), EPA sought comments on this ICR pursuant to 5 CFR 1320.8(d). EPA received no comments. Any additional comments on this ICR should be submitted to EPA and OMB within 30 days of this notice. EPA has established a public docket for this ICR under Docket ID No. EPA-HQ-OPP-2006-0860, which is available for online viewing at *www.regulations.gov* , or in-person viewing at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South Building), 2777 S. Crystal Drive, Arlington, VA. This docket facility is open from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The docket telephone number is

(703)305-5805. Use EPA's electronic docket and comment system at *www.regulations.gov* , to submit or view public comments, access the index listing of the contents of the docket, and to access those documents in the docket that are available electronically. Once in the system, select “docket search,” then key in the docket ID number identified above. Please note that EPA's policy is that public comments, whether submitted electronically or in paper, will be made available for public viewing at *www.regulations.gov* as EPA receives them and without change, unless the comment contains copyrighted material, confidential business information (CBI), or other information whose public disclosure is restricted by statute. For further information about the electronic docket, go to *www.regulations.gov.* *Title:* Plant-Incorporated Protectants; CBI Substantiation and Adverse Effects Reporting *ICR Numbers:* EPA ICR No. 1693.05, OMB Control No. 2070-0142 *ICR Status:* This ICR is scheduled to expire on October 31, 2007. Under OMB regulations, the Agency may continue to conduct or sponsor the collection of information while this submission is pending at OMB. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information, unless it displays a currently valid OMB control number. The OMB control numbers for EPA's regulations in title 40 of the CFR, after appearing in the **Federal Register** when approved, are listed in 40 CFR part 9, are displayed either by publication in the **Federal Register** or by other appropriate means, such as on the related collection instrument or form, if applicable. The display of OMB control numbers in certain EPA regulations is consolidated in 40 CFR part 9. *Abstract:* This ICR addresses the two information collection requirements described in regulations pertaining to pesticidal substances that are produced by plants (plant-incorporated protectants) and which are codified in 40 CFR part 174. A plant-incorporated protectant is defined as “the pesticidal substance that is intended to be produced and used in a living plant and the genetic material necessary for the production of such a substance.” Many, but not all, plant-incorporated protectants are exempt from registration requirements under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Registrants sometimes include in a submission to EPA for registration of a plant-incorporated protectant, information that they claim to be confidential business information (CBI). CBI is protected by FIFRA and generally cannot be released to the public. Under 40 CFR part 174, whenever a registrant claims that information submitted to EPA in support of a registration application for plant-incorporated protectants contains CBI, the registrant must substantiate such claims when they are made, rather than provide it later upon request by EPA. In addition, manufacturers of plant-incorporated protectants that are otherwise exempted from the requirements of registration must report adverse effects of the plant-incorporated protectant to the Agency. Such reporting will allow the Agency to determine whether further action is needed to prevent unreasonable adverse effects to the environment. Submission of this information is mandatory. *Burden Statement:* The annual public reporting and recordkeeping burden for this collection of information is estimated to average 7 hours for an adverse effects report and 21.5 hours for substantiation of a CBI claim, per response. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, or disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; develop, acquire, install, and utilize technology and systems for the purposes of collecting, validating, and verifying information, processing and maintaining information, and disclosing and providing information; adjust the existing ways to comply with any previously applicable instructions and requirements which have subsequently changed; train personnel to be able to respond to a collection of information; search data sources; complete and review the collection of information; and transmit or otherwise disclose the information. *Respondents/Affected Entities:* Producers and importers of plant-incorporated protectants. *Estimated Number of Respondents:* 14. *Frequency of Response:* On occasion. *Estimated Total Annual Hour Burden:* 303. *Estimated Total Annual Cost:* $20,879, includes no annualized capital or O&M costs. *Changes in the Estimates:* There is no change in the number of hours in the total estimated burden currently identified in the OMB Inventory of Approved ICR Burdens. Dated: October 10, 2007. Sara Hisel-McCoy, Acting Director, Collection Strategies Division. [FR Doc. E7-20441 Filed 10-16-07; 8:45 am] BILLING CODE 6560-50-P ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPP-2007-0938; FRL-8149-2] Pesticides; Availability of Pesticide Registration Notice Announcing Formation of Agricultural Handlers Exposure Task Force AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: The Agency is announcing the availability of a Pesticide Registration Notice (PR Notice) regarding the formation of the Agricultural Handlers Exposure Task Force, L.L.C. This PR Notice was signed by the Agency on September 20, 2007 and is posted on the EPA website under PR Notice 2007-03. PR Notices are issued by the Office of Pesticide Programs

(OPP)to inform pesticide registrants and other interested persons about important policies, procedures, and registration related decisions, and serve to provide guidance to pesticide registrants and OPP personnel. This particular PR Notice provides information concerning the formation of an industry Task Force for the development of data supporting pesticide registration, in which registrants may wish to participate. FOR FURTHER INFORMATION CONTACT: Richard P. Dumas, Special Review and Reregistration Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:

(703)308-8015; fax number:

(703)308-8005; e-mail address: *dumas.richard@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? You may be potentially affected by this notice if you register agricultural pesticide products under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA). Since other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT . B. How Can I Get Copies of this Document and Other Related Information? 1. *Docket* . EPA has established a docket for this action under docket identification

(ID)number EPA-HQ-OPP-2007-0938. Publicly available docket materials are available either in the electronic docket at *http://www.regulations.gov* , or, if only available in hard copy, at the Office of Pesticide Programs

(OPP)Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The hours of operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The Docket Facility telephone number is

(703)305-5805. 2. *Electronic access* . You may access this **Federal Register** document electronically through the EPA Internet under the **Federal Register** listings at *http://www.epa.gov/fedrgstr* . II. Background A. What Action is the Agency Taking? The Agency is announcing the issuance of a Pesticide Registration Notice [PR-2007-xx] that announces the formation of the Agricultural Handlers Exposure Task Force (AHETF). When registering or periodically reviewing an existing registration, the Agency evaluates the potential risks to pesticide handlers; that is, individuals who mix, load, or apply pesticide products. In evaluating handler risks, potential pesticide exposure is considered. The AHETF was formed to develop generic handler exposure data that can be used by EPA, and other regulatory agencies responsible for assuring the safety of pesticides. The purpose of the PR Notice is to describe what data the AHETF plans to generate, to describe how EPA expects to use the data, and to inform registrants of the opportunity to join AHETF. III. Do PR Notices Contain Binding Requirements? The PR Notice discussed in this notice is intended to provide information to EPA personnel and decision makers and to pesticide registrants. While the requirements in the statutes and Agency regulations are binding on EPA and the applicants, this PR Notice is not binding on either EPA or pesticide registrants, and EPA may depart from the guidance where circumstances warrant and without prior notice. Likewise, pesticide registrants may assert that the guidance is not appropriate generally or not applicable to a specific pesticide or situation. List of Subjects Environmental protection, Administrative practice and procedure, Agricultural commodities, Pesticides and pests. Dated: September 20, 2007. Debra Edwards, Director, Office of Pesticide Programs. [FR Doc. E7-20189 Filed 10-16-07; 8:45 am] BILLING CODE 6560-50-S ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPP-2007-0941; FRL-8152-7] Carbaryl Reregistration Eligibility Decision AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: This notice announces the availability of EPA's Reregistration Eligibility Decision

(RED)for the pesticide carbaryl. The Agency's risk assessments and other related documents also are available in the carbaryl RED Docket. This RED completes the reregistration and tolerance reassessment process for carbaryl and amends an Interim Reregistration Eligibility Decision (IRED), which was made available for public comment on October 22, 2004 (see docket EPA-HQ-OPP-2003-0376). Carbaryl is an N-methyl carbamate insecticide that is used on a variety of ornamental and agricultural crops and in residential settings, for lawns, gardens, and flea control. EPA has reviewed carbaryl through the public participation process that the Agency uses to involve the public in developing pesticide reregistration and tolerance reassessment decisions. Through these programs, EPA is ensuring that all pesticides meet current health and safety standards. FOR FURTHER INFORMATION CONTACT: Christina Scheltema, Special Review and Reregistration Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:

(703)308-2201; fax number:

(703)308-8005; e-mail address *: scheltema.christina@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? This action is directed to the public in general, and may be of interest to a wide range of stakeholders including environmental, human health, and agricultural advocates; the chemical industry; pesticide users; and members of the public interested in the sale, distribution, or use of pesticides. Since others also may be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT . B. How Can I Get Copies of this Document and Other Related Information? 1. *Docket* . EPA has established a docket for this action under docket identification

(ID)number EPA-HQ-OPP-2007-0941. Publicly available docket materials are available either in the electronic docket at *http://www.regulations.gov* , or, if only available in hard copy, at the Office of Pesticide Programs

(703)305-5805. 2. * Electronic access* . You may access this **Federal Register** document electronically through the EPA Internet under the “ **Federal Register** ” listings at *http://www.epa.gov/fedrgstr.* II. Background A. What Action is the Agency Taking? Under section 4 of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), EPA is reevaluating existing pesticides to ensure that they meet current scientific and regulatory standards. EPA has completed a RED for the pesticide carbaryl under section 4(g)(2)(A) of FIFRA. Carbaryl is an N-methyl carbamate insecticide that is used on a variety of ornamental and agricultural crops and in residential settings, for lawns, gardens, and flea control. EPA has determined that the database to support reregistration is substantially complete and that products containing carbaryl are eligible for reregistration, depending on their specific uses, provided the risks are mitigated either in the manner described in the RED and IRED or by another means that achieves equivalent risk reduction. Upon submission of any required product specific data under section 4(g)(2)(B) of FIFRA and any necessary changes to the registration and labeling (either to address concerns identified in the RED or as a result of product specific data), EPA will make a final reregistration decision under section 4(g)(2)(C) of FIFRA for products containing carbaryl. EPA is applying the principles of public participation to all pesticides undergoing reregistration and tolerance reassessment. The Agency's Pesticide Tolerance Reassessment and Reregistration; Public Participation Process, published in the **Federal Register** on May 14, 2004, (69 FR 26819) (FRL-7357-9) explains that in conducting these programs, EPA is tailoring its public participation process to be commensurate with the level of risk, extent of use, complexity of issues, and degree of public concern associated with each pesticide. EPA worked extensively with stakeholders and the public to reach the regulatory decisions for both the carbaryl IRED and RED. The carbaryl IRED was developed through the full 6 phase public participation process, and the carbaryl RED was developed through additional stakeholder collaboration. The reregistration program is being conducted under congressionally mandated time frames, and EPA recognizes the need both to make timely decisions and to involve the public. Because all issues related to this pesticide were resolved through consultations with stakeholders, the Agency is issuing the carbaryl RED without a comment period. B. What is the Agency's Authority for Taking this Action? Section 4(g)(2) of FIFRA, as amended, directs that, after submission of all data concerning a pesticide active ingredient, “the Administrator shall determine whether pesticides containing such active ingredient are eligible for reregistration,” before calling in product specific data on individual end-use products and either reregistering products or taking other “appropriate regulatory action.” List of Subjects Environmental protection, Carbaryl, Pesticides and pests. Dated: October 3, 2007, Steven Bradbury, Director, Special Review and Reregistration Division, Office of Pesticide Programs. [FR Doc. E7-20104 Filed 10-16-07; 8:45 am] BILLING CODE 6560-50-S ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPP-2007-1005; FRL-8153-2] Petition to Revoke All Tolerances and Cancel All Registrations for the Pesticide Chlorpyrifos; Notice of Availability AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: EPA is seeking public comment on a September 12, 2007, petition from the National Resources Defense Council

(NRDC)and Pesticide Action Network North America (PANNA), available in docket number EPA-HQ-OPP-2007-1005, requesting that the Agency revoke all tolerances and cancel all registrations for the pesticide chlorpyrifos. The petitioners, NRDC and PANNA, request this action to obtain what they believe would be proper application of the safety standards of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and the Federal Food, Drug, and Cosmetic Act (FFDCA), section 408, as amended by the Food Quality Protection Act

(FQPA)of 1996. DATES: Comments must be received on or before December 17, 2007. ADDRESSES: Submit your comments, identified by docket identification

(ID)number EPA-HQ-OPP-2007-1005, by one of the following methods: • *Federal eRulemaking Portal* : *http://www.regulations.gov* . Follow the on-line instructions for submitting comments. • *Mail* : Office of Pesticide Programs

(OPP)Regulatory Public Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001. • *Delivery* : OPP Regulatory Public Docket (7502P), Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only accepted during the Docket's normal hours of operation (8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays). Special arrangements should be made for deliveries of boxed information. The Docket Facility telephone number is

(703)305-5805. *Instructions* : Direct your comments to docket ID number EPA-HQ-OPP-2007-1005. EPA's policy is that all comments received will be included in the docket without change and may be made available on-line at *http://www.regulations.gov* , including any personal information provided, unless the comment includes information claimed to be Confidential Business Information

(CBI)or other information whose disclosure is restricted by statute. Do not submit information that you consider to be CBI or otherwise protected through regulations.gov or e-mail. The regulations.gov website is an “anonymous access” system, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an e-mail comment directly to EPA without going through regulations.gov, your e-mail address will be automatically captured and included as part of the comment that is placed in the docket and made available on the Internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of your comment and with any disk or CD-ROM you submit. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects or viruses. *Docket* : All documents in the docket are listed in the docket index available in regulations.gov. To access the electronic docket, go to *http://www.regulations.gov* , select “Advanced Search,” then “Docket Search.” Insert the docket ID number where indicated and select the “Submit” button. Follow the instructions on the regulations.gov website to view the docket index or access available documents. Although listed in the index, some information is not publicly available, e.g., CBI or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the Internet and will be publicly available only in hard copy form. Publicly available docket materials are available either in the electronic docket at *http://www.regulations.gov* , or, if only available in hard copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The hours of operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The Docket Facility telephone number is

(703)305-5805. FOR FURTHER INFORMATION CONTACT: Tom Myers, Special Review and Reregistration Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:

(703)308-8589; fax number:

(703)308-7070; e-mail address: *myers.tom@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? This action is directed to the public in general, and may be of interest to a wide range of stakeholders, including environmental, human health, and agricultural advocates; the chemical industry; pesticide users; and members of the public interested in the sale, distribution, or use of pesticides. This listing is not intended to be exhaustive, but rather provides a guide for readers regarding entities likely to be affected by this action. Since others also may be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT . B. What Should I Consider as I Prepare My Comments for EPA? 1. *Submitting CBI* . Do not submit this information to EPA through regulations.gov or e-mail. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as CBI and then identify electronically within the disk or CD-ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 2. *Tips for preparing your comments* . When submitting comments, remember to: i. Identify the document by docket ID number and other identifying information (subject heading, **Federal Register** date and page number). ii. Follow directions. The Agency may ask you to respond to specific questions or organize comments by referencing a Code of Federal Regulations

(CRA)misrepresented the risks of chlorpyrifos and that EPA failed to incorporate inhalation routes of exposure to chlorpyrifos in conducting its assessment. EPA's human health assessment of chlorpyrifos and findings on whether the tolerances for chlorpyrifos comply with the safety standard in FFDCA Section 408, as amended by the FQPA, are contained in the Interim Reregistration Eligibility Decision document for chlorpyrifos and the organophosphate CRA, which are available on EPA's pesticide webpage at *http://www.epa.gov/pesticides/reregistration/status.htm* and *http://www.epa.gov/pesticides/cumulative/2006-op/index.htm* . Docket materials for this pesticide are available in the electronic docket at *http://www.regulations.gov* ; risk assessment and related documents for this pesticide have been removed to Special Docket EPA-HQ-OPP-2007-0151. List of Subjects Environmental protection, Pesticides and pests, Chlorpyrifos, National Resources Defense Council, Pesticide Action Network North America. Dated: October 9, 2007. Steven Bradbury, Director, Special Review and Reregistration Division, Office of Pesticide Programs. [FR Doc. E7-20442 Filed 10-16-07; 8:45 am] BILLING CODE 6560-50-S ENVIRONMENTAL PROTECTION AGENCY [FRL-8483-6] Proposed CERCLA Administrative Cost Recovery Settlement; Company, Inc., Buckley Drive Waterline Superfund Site, Bennington, VT AGENCY: Environmental Protection Agency (EPA). ACTION: Notice of proposed settlement; request for public comment. SUMMARY: In accordance with Section 122(i) of the Comprehensive Environmental Response, Compensation, and Liability Act, as amended (“CERCLA”), 42 U.S.C. 9622(i), notice is hereby given of a proposed administrative settlement for recovery of past response costs concerning the Buckley Drive Waterline Superfund Site in Bennington, Vermont. The settlement requires the settling parties to pay $740,000.00 to the Hazardous Substance Superfund. The settlement includes a covenant not to sue the settling parties pursuant to Section 107(a) of CERCLA, 42 U.S.C. 9606 and 9607. For thirty

(30)days following the date of publication of this notice, the Agency will receive written comments relating to the settlement. The Agency will consider all comments received and may modify or withdraw its consent to the settlement if comments received disclose facts or considerations which indicate that the settlement is inappropriate, improper, or inadequate. The Agency's response to any comments received will be available for public inspection at One Congress Street, Boston, MA 02114-2023. DATES: Comments must be submitted on or before November 16, 2007. ADDRESSES: Comments should be addressed to the Regional Hearing Clerk, U.S. Environmental Protection Agency, Region I, One Congress Street, Suite 1100, Mailcode RAA, Boston, Massachusetts 02114-2023 and should refer to: In re: Buckley Drive Waterline Superfund Site, U.S. EPA Docket No. 01-2007-160. FOR FURTHER INFORMATION CONTACT: A copy of the proposed settlement may be obtained from Mary Jane O'Donnell, U.S. Environmental Protection Agency, Region I, Office of Site Remediation & Restoration, One Congress Street, Suite 1100, Mailcode HBT, Boston, MA 02114-2023. Dated: September 25, 2007. James T. Owens III, Director, Office of Site Remediation & Restoration. [FR Doc. E7-20437 Filed 10-16-07; 8:45 am] BILLING CODE 6560-50-P ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPPT-2007-0698; FRL-8146-1] Hazard Education before Renovation of Target Housing; State of Utah Authorization Application AGENCY: Environmental Protection Agency (EPA). ACTION: Notice; request for comments and opportunity for public hearing. SUMMARY: On October 13, 2006, EPA received an application from the State of Utah requesting authorization to administer a program in accordance with section 406(b) of the Toxic Substances Control Act (TSCA). This program ensures that owners and occupants of target housing are provided information concerning potential hazards of lead-based paint

(LBP)exposure before certain renovations are begun on that housing. In addition to providing general information on the health hazards associated with exposure to lead, the lead hazard information pamphlet advises owners and occupants to take appropriate precautions to avoid exposure to lead-contaminated dust and LBP debris that are sometimes generated during renovations. EPA believes that distribution of the pamphlet will help to reduce the exposures that cause serious lead poisonings, especially in children under age 6, who are particularly susceptible to the hazards of lead. The final rule (TSCA 406(b)) was published in the **Federal Register** of June 1, 1998. DATES: Comments must be received on or before December 3, 2007. In addition, a public hearing request may be submitted on or before October 24, 2007. ADDRESSES: Submit all written comments and/or requests for a public hearing identified by docket identification

(ID)number EPA-HQ-OPPT-2007-0698, by one of the following methods: • *Federal e-Rulemaking Portal* : *http://www.regulations.gov* . Follow the on-line instructions for submitting comments. • *Mail* : Document Control Office (7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001. • *Hand Delivery* : OPPT Document Control Office (DCO), EPA East Bldg., Rm. 6428, 1201 Constitution Ave., NW., Washington, DC. Attention: Docket ID number EPA-HQ-OPPT-2007-0698. The DCO is open from 8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The telephone number for the DCO is

(202)564-8930. Such deliveries are only accepted during the DCO's normal hours of operation, and special arrangements should be made for deliveries of boxed information. Instructions: Direct your comments to Docket ID number EPA-HQ-OPPT-2007-0689. EPA's policy is that all comments received will be included in the public docket without change and may be made available on-line at *http://www.regulations.gov* , including any personal information provided, unless the comment includes information claimed to be Confidential Business Information

(CBI)or other information whose disclosure is restricted by statute. Do not submit information that you consider to be CBI or otherwise protected through *http://www.regulations.gov* , or e-mail. The *http://www.regulations.gov* , website is an “anonymous access” system, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an e-mail comment directly to EPA without going through *http://www.regulations.gov* , your e-mail address will be automatically captured and included as part of the comment that is placed in the public docket and made available on the Internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of the comment and with any disk or CD ROM you submit. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects or viruses. For additional information about EPA's public docket, visit the EPA Docket Center homepage at: *http://www.epa.gov/epahome/dockets.htm* . Docket: All documents in the docket are listed in the docket index available in regulations.gov. To access the electronic docket, go to *http://www.regulations.gov* , select “Advanced Search,” then “Docket Search.” Insert the docket ID number where indicated and select the “Submit” button. Follow the instructions on the regulations.gov website to view the docket index or access available documents. Although listed in the index, some information is not publicly available, e.g., CBI or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, will be publicly available only in hard copy. Publicly available docket materials are available electronically at *http://www.regulations.gov* , or, if only available in hard copy, at the OPPT Docket. The OPPT Docket is located in the EPA Docket Center (EPA/DC) at Rm. 3334, EPA West Bldg., 1301 Constitution Ave., NW., Washington, DC. The EPA/DC Public Reading Room hours of operation are 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding Federal holidays. The telephone number of the EPA/DC Public Reading Room is

(202)566-1744, and the telephone number for the OPPT Docket is

(202)566-0280. Docket visitors are required to show photographic identification, pass through a metal detector, and sign the EPA visitor log. All visitor bags are processed through an X-ray machine and subject to search. Visitors will be provided an EPA/DC badge that must be visible at all times in the building and returned upon departure. FOR FURTHER INFORMATION CONTACT: Amanda Hasty, Pollution Prevention, Pesticides and Toxics Program (P3T), U.S. EPA, Region 8, 1595 Wynkoop St., Denver, CO 80202-1129; telephone number:

(303)312-6966; e-mail address: *hasty.amanda@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? You may potentially be affected by this action if you perform renovations of target housing for compensation in the State of Utah. Target housing is defined in the Code of Federal Regulations (see 40 CFR 745.103) as any housing constructed prior to 1978. Potentially affected entities may include, but are not limited to: • Renovators (North American Industrial Classification System (NAICS) code 236116, 236118), e.g., general building contractors/operative builders, renovation firms, individual contractors, and special trade contractors like carpenters, painters, drywall workers and lathers, “home improvement” contractors. • Multi-family housing owners/managers (NAICS code 531311, 531110), e.g., property management firms and some landlords. This listing is not intended to be exhaustive, but rather provides a guide for readers regarding entities likely to be affected by this action. Other types of entities not listed in this unit could also be affected. The NAICS codes have been provided to assist you and others in determining whether this action might apply to certain entities. To determine whether you or your business may be affected by this action, you should carefully examine the applicability provisions in 40 CFR 745.82. If you have any questions regarding the applicability of this action to a particular entity, consult the technical person listed under FOR FURTHER INFORMATION . B. What Should I Consider as I Prepare My Comments for EPA? 1. *Submitting CBI* . Do not submit this information to EPA through *http://www.regulations.gov* , or e-mail. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD ROM that you mail to EPA, mark the outside of the CD ROM or disk as CBI and then identify electronically within the disk or CD ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 2. *Tips for preparing your comments* . When submitting comments, remember to: i. Identify the document by docket ID number and other identifying information (subject heading, **Federal Register** date and page number). ii. Follow directions. EPA may ask you to respond to specific questions or organize comments by referencing a Code of Federal Regulations

(CFR)part or section number. iii. Explain why you agree or disagree; suggest alternatives and substitute language for your requested changes. iv. Describe any assumptions and provide any technical information and/or data that you used. v. If you estimate potential costs or burdens, explain how you arrived at your estimate in sufficient detail to allow for it to be reproduced. vi. Provide specific examples to illustrate your concerns and suggest alternatives. vii. Explain your views as clearly as possible, avoiding the use of profanity or personal threats. viii. Make sure to submit your comments by the comment period deadline identified. II. Background A. What Action is the Agency Taking? The State of Utah has provided a self-certification letter stating that its pre-renovation notification program meets the requirements for authorization of a state program under section 404 of TSCA and has requested approval of the Utah pre-renovation notification program. Therefore, pursuant to section 404 of TSCA, the program is deemed authorized as of the date of submission, October 13, 2006. If EPA subsequently finds that the program does not meet all the requirements for approval of a state program, EPA will work with the state to correct any deficiencies in order to approve the program. If the deficiencies are not corrected, a notice of disapproval will be issued in the **Federal Register** and a Federal program will be implemented in the State. Pursuant to section 404(b) of TSCA (15 U.S.C. 2684(b)), EPA provides notice and an opportunity for a public hearing on a state or tribal program application before approving the application. Therefore, by this notice EPA is soliciting public comment on whether the State of Utah application meets the requirements for EPA approval. This notice also provides an opportunity to request a public hearing on the application. If a hearing is requested and granted, EPA will issue a **Federal Register** notice announcing the date, time, and place of the hearing. EPA's final decision on the application will be published in the **Federal Register** . B. What is the Agency's Authority for Taking this Action? On October 28, 1992, the Housing and Community Development Act of 1992, Public Law 102-550, became law. Title X of that statute was the Residential Lead-Based Paint Hazard Reduction Act of 1992. That Act amended TSCA (15 U.S.C. 2601 *et seq.* ) by adding Title IV (15 U.S.C. 2681-2692), entitled *Lead Exposure Reduction* . Section 402 of TSCA (15 U.S.C. 2682) authorizes and directs EPA to promulgate final regulations governing LBP activities in target housing, public and commercial buildings, bridges and other structures. Those regulations are to ensure that individuals engaged in such activities are properly trained, that training programs are accredited, and that individuals engaged in these activities are certified and follow documented work practice standards. Under section 404 of TSCA (15 U.S.C. 2684), a State may seek authorization from EPA to administer and enforce its own LBP paint activities program. In the **Federal Register** of August 29, 1996 (61 FR 45777) (FRL-5389-9), EPA promulgated final TSCA section 402/404 regulations governing LBP activities in target housing and child-occupied facilities (a subset of public buildings). Those regulations are codified at 40 CFR part 745, and allow both states and Indian tribes to apply for program authorization. Pursuant to section 404(h) of TSCA (15 U.S.C. 2684(h)), EPA is to establish the Federal program in any state or tribal nation without its own authorized program in place by August 31, 1998. States and tribes that choose to apply for program authorization must submit a complete application to the appropriate regional EPA office for review. Those applications will be reviewed by EPA within 180 days of receipt of the complete application. To receive EPA approval, a state or tribe must demonstrate that its program is at least as protective of human health and the environment as the Federal program, and provides for adequate enforcement (section 404(b) of TSCA, 15 U.S.C. 2684(b)). EPA's regulations (40 CFR part 745, subpart Q) provide the detailed requirements a State or Tribal program must meet in order to obtain EPA approval. A state may choose to certify that its LBP activities program (40 CFR part 745, subpart L) and/or pre-renovation notification program (40 CFR part 745, subpart E) meets the requirements for EPA approval, by submitting a letter signed by the Governor or Attorney General stating that the program meets the requirements of section 404(b) of TSCA. Upon submission of such certification letter, the program is deemed authorized (15 U.S.C. 2684(a)). This authorization becomes ineffective, however, if EPA disapproves the application or withdraws the program authorization. III. State Program Description Summary The following summary of the State of Utah proposed pre-renovation education program was provided by the applicant. During the 1998 Utah legislative session, Senate Bill 118 (SB 118) was unanimously passed by both the House and the Senate. SB 118 amends Utah Code Annotated

(UCA)Section 19-2-104 of the Utah Air Conservation Act, which provides authority for the Utah Air Quality Board (Board) to make administrative rules for a Utah LBP Program. The legislation specifically gives authority to the Board to make rules for training, certification and performance requirements in accordance with sections 402 and 404 of subchapter IV of TSCA. SB 118 also provides the Board with the authority to establish work practices, certification and clearance sampling requirements for persons who conduct LBP inspections in facilities subject to TSCA Title IV. The legislation also specifically gives the Board the authority to establish certification requirements for inspectors, risk assessors, supervisors, project designers and abatement workers when performing LBP activities subject to TSCA Title IV. During the 2003 legislative session, House Bill 165 incorporated a change to UCA 19-2-104(1)(i) giving the Board the authority to make administrative rules for programs authorized by TSCA section 406. The Utah Attorney General's Office reviewed the content of SB 118 prior to enactment and determined that SB 118 would provide the Board with the necessary legislative authority to develop a Utah LBP Program that is as protective as the Federal LBP Program (Title 40 Code of Federal Regulations (40 CFR part 745)). *Administrative Rule Summary* On August 3, 2005, the Utah Department of Environmental Quality/Division of Air Quality (UDEQ/DAQ) provided the Board with a proposed modification to Utah Administrative Code

(UAC)R307-840--Lead-Based Paint Accreditation, Certification and Work Practice Standards to establish the rules necessary for the Utah LBP Program to administer 40 CFR part 745, subpart E--Residential Property Renovation which is otherwise known as the Lead Pre-Renovation Education Rule. UAC R307-840 substantially adopts 40 CFR part 745, subpart E by reference. On November 2, 2005, the UDEQ/DAQ reported back to the Board that no public comments were received during the public hearing period. The Board subsequently adopted the UDEQ/DAQ proposed modifications to the existing version of UAC R307-840 (Appendix 4) with an effective date of November 3, 2005. UAC R307-840 incorporates the federal regulation with a few modifications to facilitate LBP program implementation by the State of Utah. The UDEQ/DAQ considers these modifications necessary to implement an effective LBP program and also considers these modifications to be as protective to human health and the environment as the federal LBP program. The following paragraphs provide a brief summary of the three sections in UAC R307-840. Each section will identify which parts in 40 CFR part 745, subpart E are adopted by reference and give a brief overview of its contents. Throughout UAC R307-840, nearly all references to “EPA” (the U.S. Environmental Protection Agency) when used for LBP program administrative activities have been replaced with “the Executive Secretary” (meaning Executive Secretary of the Utah Air Quality Board). *R307-840-1: Purpose and Applicability* No modifications were made to this section during this rulemaking. *R307-840-2: Definitions* This section substantially adopts 40 CFR 745.83 by reference. The reference to EPA in the definition of “Pamphlet” was not replaced with “the Executive Secretary” in this particular instance because it was inappropriate to do such. *R307-840-3: Accreditation, Certification and Work Standards: Target Housing and Child-Occupied Facilities* UAC R307-840-3 adopts 40 CFR 745.80, 745.81, 745.82, 745.85, 745.86, and 745.88 from the federal LBP regulations by reference. This section of the Utah LBP rule outlines the requirements for Utah LBP work practice standards as it applies to the Utah Pre-Renovation Education Rule. UAC R307-840-3 creates some minor modifications to the federal LBP regulations to facilitate program implementation in Utah. The reference to EPA in 40 CFR 745.86(b)(1) was not replaced with “the Executive Secretary” in this particular instance because it was inappropriate to do such. Two references to federal regulations found in 40 CFR 745.82(b)(3) and 745.86(b)(1) were replaced with R307-840 to facilitate program administration in Utah. Errors found in 40 CFR 745.86(b)(1), 745.88(b)(2)(i), and 745.88(b)(2)(ii) were corrected in UAC R307-840 by Utah rulemaking. IV. Federal Overfiling Section 404(b) of TSCA makes it unlawful for any person to violate, or fail or refuse to comply with, any requirement of an approved State or Tribal program. Therefore, EPA reserves the right to exercise its enforcement authority under TSCA against a violation of, or a failure or refusal to comply with, any requirement of an authorized State or Tribal program. V. Submission to Congress and the Comptroller General The Congressional Review Act, 5 U.S.C. 801 *et seq* ., as added by the Small Business Regulatory Enforcement Fairness Act of 1996, generally provides that before certain actions may take effect, the agency promulgating the action must submit a report, which includes a copy of the action, to each House of the Congress and to the Comptroller General of the United States. EPA will submit a report containing this action and other required information to the U.S. Senate, the U.S. House of Representatives, and the Comptroller General of the United States prior to publication of this document in the **Federal Register** . This action is not a “major rule” as defined by 5 U.S.C. 804(2). List of Subjects Environmental protection, Hazardous substances, Lead, Renovation notification, Reporting and recordkeeping requirements. Dated: September 17, 2007. Kerrigan G. Clough, Region 8, Acting Administrator. [FR Doc. E7-20446 Filed 10-16-07; 8:45 am] BILLING CODE 6560-50-S FEDERAL COMMUNICATIONS COMMISSION [DA 07-4132] Consumer Advisory Committee AGENCY: Federal Communications Commission. ACTION: Notice. SUMMARY: The Commission announces the next meeting date and agenda of its Consumer Advisory Committee (“Committee”). The purpose of the Committee is to make recommendations to the Commission regarding consumer issues within the jurisdiction of the Commission and to facilitate the participation of all consumers in proceedings before the Commission. DATES: The next meeting of the Committee will take place on Friday, November 2, 2007, 9 a.m. to 4 p.m. ADDRESSES: Federal Communications Commission, 445 12th Street, NW., Room TW-C305, Washington, DC 20554. FOR FURTHER INFORMATION CONTACT: Scott Marshall, Consumer & Governmental Affairs Bureau,

(202)418-2809 (voice),

(202)418-0179 (TTY), or e-mail *scott.marshal@fcc.gov* . SUPPLEMENTARY INFORMATION: On October 10, 2007, the Commission released document DA 07-4132, which announced the agenda, date and time of the next Consumer Advisory Committee meeting. At its November 2, 2007 meeting, the Committee will continue its consideration of digital television

(DTV)outreach including a demonstration of converter box technology. The Committee will also consider other consumer issues within the jurisdiction of the Commission. A limited amount of time on the agenda will be available for oral comments from the public. The Committee is organized under and operates in accordance with the provisions of the Federal Advisory Committee Act, 5 U.S.C. App. 2 (1988). The meeting is open to the public. Members of the public may address the Committee or may send written comments to: Scott Marshall, Designated Federal Officer of the Committee, at the address indicated on the first page of this document. The meeting site is accessible to people with disabilities. Meetings are sign language interpreted with real-time transcription and assistive listening devices available. Meeting agendas are provided in accessible formats. To request materials in accessible formats for people with disabilities (Braille, large print, electronic files, audio format), send an e-mail to *fcc504@fcc.gov* or call the Consumer & Governmental Affairs Bureau at 202-418-0530 (voice), 202-418-0432 (TTY). Federal Communications Commission. Thomas D. Wyatt, Deputy Bureau Chief, Consumer & Governmental Affairs Bureau. [FR Doc. E7-20503 Filed 10-16-07; 8:45 am] BILLING CODE 6712-01-P FEDERAL MARITIME COMMISSION Notice of Agreements Filed The Commission hereby gives notice of the filing of the following agreements under the Shipping Act of 1984. Interested parties may submit comments on agreements to the Secretary, Federal Maritime Commission, Washington, DC 20573, within ten days of the date this notice appears in the **Federal Register** . Copies of agreements are available through the Commission's Office of Agreements (202-523-5793 or *tradeanalysis@fmc.gov* ). *Agreement No.:* 010071-034. *Title:* Cruise Lines International Association Agreement. *Parties:* American Cruise Lines, Inc.; Carnival Cruise Lines; Celebrity Cruises, Inc.; Costa Cruise Lines; Crystal Cruises; Cunard Line; Disney Cruise Line; Holland America Line; MSC Cruises; Norwegian Coastal Voyage, Inc./Bergen Line Services; Norwegian Cruise Line; Oceania Cruises; Orient Lines; Princess Cruises; Regent Seven Seas Cruises; Royal Caribbean International; Seabourn Cruise Line; SeaDream Yacht Club; Silversea Cruises, Ltd. and Windstar Cruises. *Filing Party:* Robert Sharak, VP Marketing & Distribution; Cruise Lines International Association; 910 SE 17th Street Ste 400, Fort Lauderdale, FL 33316. *Synopsis:* The amendment would add Azamara Cruises, Inc., Majestic America Line, and Uniworld River Cruises, Inc. as parties to the agreement. *Agreement No.:* 011488-003. *Title:* CSAV/NYKCool Space Charter Agreement. *Parties:* CSAV Sud Americana de Vapores S.A. and NYKCool AB. *Filing Party:* Wayne R. Rohde, Esq.; Sher & Blackwell LLP; 1850 M Street NW; Suite 900; Washington, DC 20036. *Synopsis:* The amendment changes the name LauritzenCool AB to NYKCool AB in the agreement, and republishes the agreement to reflect these changes. By Order of the Federal Maritime Commission. Dated: October 11, 2007. Bryant L. VanBrakle, Secretary. [FR Doc. E7-20414 Filed 10-16-07; 8:45 am] BILLING CODE 6730-01-P FEDERAL MARITIME COMMISSION Ocean Transportation Intermediary License Applicants Notice is hereby given that the following applicants have filed with the Federal Maritime Commission an application for license as a Non-Vessel Operating Common Carrier and Ocean Freight Forwarder—Ocean Transportation Intermediary pursuant to section 19 of the Shipping Act of 1984 as amended (46 U.S.C. Chapter 409 and 46 CFR part 515). Persons knowing of any reason why the following applicants should not receive a license are requested to contact the Office of Transportation Intermediaries, Federal Maritime Commission, Washington, DC 20573. Non-Vessel Operating Common Carrier Ocean Transportation Intermediary Applicants Pacific Groupage Services, Inc., 9024 Foxwood Drive, Keller, TX 76248. Officers: Michael L. Hayhurst, Vice President (Qualifying Individual), Yatendra Malhotra, President. Cargonline

(USA)Inc., 245 E. Main Street, #112, Alhambra, CA 91801. Officers: Stephen Ming-Hong Kiang, Vice President (Qualifying Individual), Wailun Hon, President. Kardel Enterprises Inc. dba Pakya, 1557 NW 82nd Avenue, Doral, FL 33126. Officers: Martha S. Ramos, General Manager (Qualifying Individual), Margarita Levis, President. Driver's Diversified, Inc. dba Double D Logistics, Inc., P.O. Box 208, Stony Ridge, OH 43463. Officers: James R. Jacobs, President, John J. Ertle, Vice President (Qualifying Individuals). Ocean Star Logistics Inc., 2200 South Fremont Ave., Suite 202, Alhambra, CA 91803, Janet Li, President (Qualifying Individual). Neptune Shipping Limited dba Novalink Logistics, 1223 S. Monterey Street, Alhambra, CA 91801. Officers: Yao Yao Guo, Vice President (Qualifying Individual), Xucai Xu, President. Pacific Delta Lines, Inc., 4733 Torrance Blvd., Ste. 168, Torrance, CA 90503. Officers: Waingan Woo, Secretary (Qualifying Individual), Wanlan Zhang, President. United Marine Management, 20160 Paseo Del Pardo, Ste. H, Walnut, CA 91789. Officer: Yanli (Yvonne) Y. Liu, President (Qualifying Individual). Non-Vessel Operating Common Carrier and Ocean Freight Forwarder Transportation Intermediary Applicants KYN International Inc., 11700 NW 101st Road, Ste. 6, Miami, FL 33178. Officers: Noel Quintana, President (Qualifying Individual), Kelsy Quintana, Vice President. Panorama Services & Travel Corp., 10510 W. Flagler Street, Miami, FL 33174. Officers: Norman Ali, Uriarte, General Manager (Qualifying Individual), Norman Aly Uriarte, President. Ambert Inc. dba Afreican Express Lines, 249 Merrifield Avenue, Oceanside NY 11572. Officer: Selina Megertichian-Feinstein, President (Qualifying Individual). Joker Logistics

(USA)Inc., 11200 Metro Airport Center Dr., Ste. 100, Romulus, MI 48174. Officers: Daniel Hradetzky, Vice President (Qualifying Individual), Roland Mischke, Managing Director. Glovis America, Inc., 1665 Scenic Avenue, Ste. 250, Costa Mesa, CA 92626. Officers: Tae Woo Kim, Vice President (Qualifying Individual), ChiwoongKim, CEO. Ocean Freight Forwarder—Ocean Transportation Intermediary Applicants FA Logistics International Corp., 6995 NW 82nd Avenue, Miami, FL 33166. Officer: Franklin Almeida, President (Qualifying Individual). JAV Cargo, Inc., 4249 Remo Crescent Drive, Bensalem, PA 19020. Officer: John Allen Bustamante Villarin, President (Qualifying Individual). Manns Freight Systems, Inc. dba Guardian Global Transport, 2440 Enterprise Drive, Mendota Heights, MN 55120. Officers: Mike Sweeney, Secretary (Qualifying Individual), Alan Meehan, President. Apac Logistic Transportation, 840 Hinckley Road, #138, Burlingame, CA 94010. Officers: Pei-Qing Gu, Vice President (Qualifying Individual), Sylvia Mortgat, President. Continuum International Logistics, Inc., 61 Gray's Bridge Road, Brookfield, CT 06877. Officers: Steven Hitchcock, President (Qualifying Individual), John McAuliffe, C-President. Automated Cargo Transport Service, Inc. dba ACTS, 9 Barkentine Road, Rancho Palos Verdes, CA 90275. Officer: Richard Alton Schleicher, CEO (Qualifying Individual). Dated: October 11, 2007. Bryant L. VanBrakle, Secretary. [FR Doc. E7-20412 Filed 10-16-07; 8:45 am] BILLING CODE 6730-01-P FEDERAL RESERVE SYSTEM Agency Information Collection Activities: Announcement of Board Approval Under Delegated Authority and Submission to OMB SUMMARY: Background. Notice is hereby given of the final approval of proposed information collections by the Board of Governors of the Federal Reserve System (Board) under OMB delegated authority, as per 5 CFR 1320.16 (OMB Regulations on Controlling Paperwork Burdens on the Public). Board-approved collections of information are incorporated into the official OMB inventory of currently approved collections of information. Copies of the Paperwork Reduction Act Submission, supporting statements and approved collection of information instrument(s) are placed into OMB's public docket files. The Federal Reserve may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. FOR FURTHER INFORMATION CONTACT: Federal Reserve Board Clearance Officer -Michelle Shore--Division of Research and Statistics, Board of Governors of the Federal Reserve System, Washington, DC 20551 (202-452-3829) OMB Desk Officer-Alexander T. Hunt--Office of Information and Regulatory Affairs, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503. Final approval under OMB delegated authority of the extension for three years, with revision, of the following report: *1. Report title:* Interagency Bank Merger Act Application *Agency form number:* FR 2070 *OMB control number:* 7100-0171 *Frequency:* On occasion *Reporters:* State member banks *Annual reporting hours:* Nonaffiliate Transactions: 1,560; Affiliate Transactions: 234 *Estimated average hours per response:* Nonaffiliate Transactions: 30; Affiliate Transactions: 18 *Number of respondents:* Nonaffiliate Transactions: 52; Affiliate Transactions: 13 *General description of report:* This information collection is mandatory (12 U.S.C. 1828(c)) and is not given confidential treatment. However, applicants may request that parts of a submitted application be kept confidential. In such cases, the burden is on the applicant to justify the exemption by demonstrating that disclosure would cause substantial competitive harm or result in an unwarranted invasion of personal privacy or would otherwise qualify for an exemption under the Freedom of Information Act (5 U.S.C. 552). The confidentiality status of the information submitted will be judged on a case-by-case basis. *Abstract:* The Federal Reserve, the Office of the Comptroller of the Currency (OCC), the Federal Deposit Insurance Corporation

(FDIC)and the Office of Thrift Supervision

(OTS)(the agencies) each use this application form to collect information for bank merger proposals that require prior approval under the Bank Merger Act. Prior approval is required for every merger transaction involving affiliated or nonaffiliated institutions and must be sought from the regulatory agency of the depository institution that would survive the proposed transaction. A merger transaction may include a merger, consolidation, assumption of deposit liabilities, or certain asset-transfers between or among two or more institutions. The Federal Reserve collects this information so that it may meet its statutory obligation to evaluate the competitive, financial, managerial, future prospects, and convenience and needs aspects of each state member bank merger proposal. *Current Actions:* The Federal Reserve will update the General Information and Instructions to reflect passage of the Federal Deposit Insurance Reform Act of 2005, which was enacted on February 8, 2006. Provisions of this legislation directed the merger of the Bank Insurance Fund and the Savings Association Insurance Fund into a new Deposit Insurance Fund. The formation of the single insurance fund eliminated the need for two types of insurance-related applications that had been required for certain bank merger transactions. The revisions relate entirely to the eliminated filing requirements. On July 18, 2007, the Federal Reserve published a notice in the Federal Register (72 FR 39429) requesting public comment for sixty days on the extension, with revision, of the Interagency Bank Merger Act Application; the comment period expired on September 17, 2007. The Federal Reserve did not receive any comments. The revisions will be implemented as proposed. On August 7, 2007, the OCC and FDIC published a separate Federal Register notice (72 FR 44220) requesting public comment for sixty days on these revisions; the comment period expired on October 9, 2007. The OTS will publish a separate Federal Register notice requesting public comment on these revisions. *2. Report title:* Intermittent Survey of Businesses *Agency form number:* FR 1374 *OMB control number:* 7100-0302 *Frequency:* on occasion *Reporters:* businesses *Annual reporting hours:* 205 *Estimated average hours per response:* 15 minutes *Number of respondents:* 250 *General description of report:* This information collection is voluntary (12 U.S.C. 225a and 263) and may be given confidential treatment (5 U.S.C. 552(b)(4)). *Abstract:* The survey data are used by the Federal Reserve to gather information specifically tailored to the Federal Reserve's policy and operational responsibilities. There are two parts to this event-generated survey. First, the Federal Reserve Banks survey business contacts as economic developments warrant. Currently, they conduct these surveys two times per year, with approximately 120 business respondents for each survey (about ten per Reserve Bank). Usually, these surveys are conducted by Reserve Bank economists telephoning or emailing purchasing managers, economists, or other knowledgeable individuals at selected, relevant businesses. The frequency and content of the questions, as well as the businesses contacted, vary depending on changing developments in the economy. Second, economists at the Board survey business contacts by telephone, inquiring about current business conditions. Historically, these surveys have been conducted biweekly, with approximately ten respondents for each survey. *Current actions:* The Federal Reserve will revise the frequency of both parts of the survey in response to recent changes in the demand for these data by the Board members. The Reserve Bank portion of the survey will be conducted as economic events dictate (about three times per year). The Board portion of the survey will be conducted on an event-generated basis, no more than ten times per year. In addition, the Federal Reserve will increase the number of respondents for the Reserve Bank part of the survey from 120 to 240 (twenty per Reserve Bank). On July 23, 2007, the Federal Reserve published a notice in the Federal Register (72 FR 40152) requesting public comment for sixty days on the extension, with revision, of the Intermittent Survey of Businesses; the comment period expired on September 21, 2007. The Federal Reserve did not receive any comments. The revisions will be implemented as proposed. Final approval under OMB delegated authority of the extension for three years, without revision, of the following report: *1. Report title:* Interagency Notice of Change in Control, Interagency Notice of Change in Director or Senior Executive Officer, and Interagency Biographical and Financial Report. *Agency form number:* FR 2081a, FR 2081b, and FR 2081c *OMB control number:* 7100-0134 *Frequency:* On occasion *Reporters:* Financial institutions and certain of their officers and shareholders *Annual reporting hours:* FR 2081a: 3,150; FR 2081b: 142; FR 2081c: 2,464 *Estimated average hours per response:* FR 2081a: 30; FR 2081b: 2; FR 2081c: 4 *Number of respondents:* FR 2081a: 105; FR 2081b: 71; FR 2081c: 616 *General description of report:* This information collection is mandatory (12 U.S.C. 1817(j) and 12 U.S.C. 1831(i)) and is not given confidential treatment. However, applicants may request that parts of a submitted application be kept confidential. In such cases, the burden is on the applicant to justify the exemption by demonstrating that disclosure would cause substantial competitive harm or result in an unwarranted invasion of personal privacy or would otherwise qualify for an exemption under the Freedom of Information Act (5 U.S.C. 552). The confidentiality status of the information submitted will be judged on a case-by-case basis. *Abstract:* The information collected assists the Federal Reserve, the Office of the Comptroller of the Currency (OCC), the Federal Deposit Insurance Corporation

(FDIC)and the Office of Thrift Supervision

(OTS)(the agencies) in fulfilling their statutory responsibilities as supervisors. Each of these forms is used to collect information in connection with applications and notices filed prior to proposed changes in the ownership or management of banking organizations. The agencies use the information to evaluate the controlling owners, senior officers, and directors of the insured depository institutions subject to their oversight. *Current Actions:* On July 18, 2007, the Federal Reserve published a notice in the Federal Register (72 FR 39429) requesting public comment for sixty days on the extension, without revision, of these notices and reporting form; the comment period expired on September 17, 2007. The Federal Reserve did not receive any comments. On August 7, 2007, the OCC and FDIC published a separate Federal Register notice (72 FR 44220) requesting public comment for sixty days on the extension; the comment period expired on October 9, 2007. The OTS will publish a separate Federal Register notice requesting public comment on the extension. *2. Report title:* Semiannual Report of Derivatives Activity *Agency form number:* FR 2436 *OMB control number:* 7100-0286 *Frequency:* Semiannually *Reporters:* U.S. dealers of over-the-counter derivatives *Annual reporting hours:* 2,100 *Estimated average hours per response:* 150 *Number of respondents:* 7 *General description of report:* This information collection is voluntary (12 U.S.C. 225a, 263, 348a, and 353-359) and is given confidential treatment (5 U.S.C. 552(b)(4)). *Abstract:* Data are collected on notional amounts and gross market values of outstanding OTC derivatives contracts for broad categories of market risk: foreign exchange, interest rate, equities, commodities, and credit. For the different types of market risk except commodities, further detail is collected on the underlying market risk of each contract-- the underlying currency, equity market, or reference entity (borrower). This collection of information complements the triennial Central Bank Survey of Foreign Exchange and Derivatives Market Activity (FR 3036; OMB No. 7100-0285). The FR 2436 collects similar data on the outstanding volume of derivatives, but not on derivatives turnover. The Federal Reserve conducts both surveys in coordination with other central banks and forwards the aggregated data furnished by U.S. reporters to the Bank for International Settlements, which publishes global market statistics that are aggregations of national data. *Current Actions:* On July 23, 2007, the Federal Reserve published a notice in the Federal Register (72 FR 40152) requesting public comment for sixty days on the extension, without revision, of the Semiannual Report of Derivatives Activity; the comment period expired on September 21, 2007. The Federal Reserve did not receive any comments. Board of Governors of the Federal Reserve System, October 12, 2007. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E7-20413 Filed 10-16-07; 8:45 am] BILLING CODE 6210-01-S FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than November 1, 2007. **A. Federal Reserve Bank of Kansas City** (Todd Offenbacker, Assistant Vice President) 925 Grand Avenue, Kansas City, Missouri 64198-0001: *1. Loris D. New Trust, UTA 09-07-93, Loris D. New* , Leavenworth, Kansas, trustee; to acquire voting shares of Tonganoxie Bankshares, Inc., and thereby indirectly acquire voting shares of First State Bank and Trust, both in Tonganoxie, Kansas. In connection with this application, The Damon L. New Trust, UTA 12-12-97, Damon L. New, Leavenworth, Kansas, as trustee and individually; the Jilinda A. White Trust, UTA 12-12-97, Jilinda A. White, Leavenworth, Kansas, as trustee and individually; the Shawnda D. Gilmore Trust, UTA 12-12-97, Shawnda D. Gilmore, Leavenworth, Kansas, as trustee and individually; the Brandon O. New Trust, UTA 12-12-97, Brandon O. New, Leavenworth, Kansas, as trustee and individually, as members of the New Family Group, a group acting in concert; has applied to retain voting shares of Tonganoxie Bankshares, Inc., and thereby indirectly retain voting shares of First State Bank and Trust, both in Tonganoxie, Kansas. *2. Jarrel M. Jones* , individually, as a member of the Jarrel M. Jones Family Group, and as trustee of the Jimmy K. and Annahlee Jones Trust for Matthew Howard Franks, the Jimmy K. and Annahlee Jones Trust for Michael James Franks, the Jimmy K. and Annahlee Jones Trust for Mark William Franks, the Jimmy K. and Annahlee Jones Trust for Annahlyn Dawn Jones, the Jimmy K. and Annahlee Jones Trust for Emmie Kathryn Jones, the Jimmy K. and Annahlee Jones Trust for James Ryan Jones, the Jimmy K. and Annahlee Jones Trust for Jeffrey Allen Jones, the Jimmy K. and Annahlee Jones Trust for Laura Janell Jones, the Jimmy K. and Annahlee Jones Trust for Jennifer Lee Jones, the Jimmy K. and Annahlee Jones Trust for James Christopher Jones, the Jimmy K. and Annahlee Jones Trust for James Eric Jones, the Jimmy K. and Annahlee Jones Trust for Jordan Elijah Helmerich, the Jimmy K. and Annahlee Jones Trust for Erica Elicia Helmerich, the Jimmy K. and Annahlee Jones Trust for Jason William Deck, the Jimmy K. and Annahlee Jones Trust for James Bryan Deck, the Jimmy K. and Annahlee Jones Trust for Jessie Anna Deck; James C. Jones, James E. Jones, all of Tulsa, Oklahoma, and Jennifer Lee Carroll, Bixby, Oklahoma, as members of the Jarrel M. Jones Family Group; to acquire voting shares of Triad Bancshares, Inc., and thereby indirectly acquire voting shares of Triad Bank, National Association, both in Tulsa, Oklahoma. Board of Governors of the Federal Reserve System, October 12, 2007. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E7-20422 Filed 10-16-07; 8:45 am] BILLING CODE 6210-01-S FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 *et seq.* ) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center Web site at *www.ffiec.gov/nic/* . Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than November 9, 2007. **A. Federal Reserve Bank of Kansas City** (Todd Offenbacker, Assistant Vice President) 925 Grand Avenue, Kansas City, Missouri 64198-0001: *1. Central Bancorp, Inc.* ; to become a bank holding company by acquiring 100 percent of the voting shares of Central Bank & Trust (in organization), both of Colorado Springs, Colorado. In connection with this application, Applicant also has applied to acquire Elite Properties of America II, Inc.; CB&T Mortgage, Inc.; CityFirst Mortgage, LLC; and CB&T Wealth Management, Inc.; all of Colorado Springs, Colorado; and CB&T Trust, LLC, Sioux Falls, South Dakota; and thereby engage in extending credit, servicing loans, trust activities, and financial and investment advisory activities, pursuant to sections 225.28(b)(1); 225.28(b)(5); 225.28(b)(6)(i) and 225.28(b)(6)(v) of Regulation Y. Board of Governors of the Federal Reserve System, October 11, 2007. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc.E7-20370 Filed 10-16-07; 8:45 am] BILLING CODE 6210-01-S FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 *et seq.* ) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at *www.ffiec.gov/nic/* . Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than November 13, 2007. **A. Federal Reserve Bank of Minneapolis** (Jacqueline G. King, Community Affairs Officer) 90 Hennepin Avenue, Minneapolis, Minnesota 55480-0291: *1. First Interstate BancSystem, Inc.* , Billings, Montana; to acquire 100 percent of the voting shares of First Western Bank, Wall, South Dakota, and The First Western Bank of Sturgis, Sturgis, South Dakota. *2. Ramsey Financial Corporation and Affiliates Employee Stock Ownership Plan* ; to become a bank holding company by acquring additional voting shares, for a total of at least 50.7 percent, of the voting shares of Ramsey Financial Corporation, and thereby indirectly acquire voting shares of Ramsey National Bank and Trust Company of Devils Lake, all of Devils Lake, North Dakota. **B. Federal Reserve Bank of Dallas** (W. Arthur Tribble, Vice President) 2200 North Pearl Street, Dallas, Texas 75201-2272: *1. The Jarrel Morris Jones Family, LLC* , to become a bank holding company by acquiring 35.4 percent of the voting shares of Triad Bancshares, Inc., and thereby indirectly acquire voting shares of Triad Bank, National Association, all of Tulsa, Oklahoma. *2. Lone Star State Bancshares, Inc.* , Lubbock, Texas; to become a bank holding company by acquiring 100 percent of the voting shares of Lone Star State Bank of West Texas, Lubbock, Texas, a *de novo* bank. *3. A.N.B. Holding Company, Ltd., and The ANB Corporation* , both of Terrell, Texas, to acquire 100 percent of the voting shares of DNB Bancshares, Inc., Dallas, Texas, and thereby indirectly acquire voting shares of DNB Delaware Financial Corporation, Dover, Delaware, and Dallas National Bank, Dallas, Texas. Board of Governors of the Federal Reserve System, October 12, 2007. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E7-20421 Filed 10-16-07; 8:45 am] BILLING CODE 6210-01-S FEDERAL RESERVE SYSTEM Notice of Proposals to Engage in Permissible Nonbanking Activities or to Acquire Companies that are Engaged in Permissible Nonbanking Activities The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y (12 CFR Part 225) to engage *de novo* , or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Additional information on all bank holding companies may be obtained from the National Information Center website at *www.ffiec.gov/nic/* . Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than November 13, 2007. **A. Federal Reserve Bank of San Francisco** (Tracy Basinger, Director, Regional and Community Bank Group) 101 Market Street, San Francisco, California 94105-1579: *1. Castle Creek Capital Partners III LP, Castle Creek Capital III LLC, Eggemeyer Capital LLC, Ruh Capital LLC, and Legions IV Advisory Corp.* , all of Rancho Santa Fe, California; to acquire additional voting shares, for a total of 42 percent, of the votings shares of Atlanta Bancorporation, and thereby, indirectly acquire additional voting shares of Bank of Atlanta FSB, both of Atlanta, Georgia, and thereby engage in operating a savings association, pursuant to section 225.28(b)(4)(ii) of Regulation Y. Board of Governors of the Federal Reserve System, October 12, 2007. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E7-20420 Filed 10-16-07; 8:45 am] BILLING CODE 6210-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Toxicology Program (NTP); Liaison and Scientific Review Office; Meeting of the NTP Board of Scientific Counselors AGENCY: National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, HHS. ACTION: Meeting announcement and request for comments. SUMMARY: Pursuant to Public Law 92-463, notice is hereby given of a meeting of the NTP Board of Scientific Counselors (NTP BSC). The NTP BSC is composed of scientists from the public and private sectors and provides primary scientific oversight to the NTP Director and evaluates the scientific merit of the NTP's intramural and collaborative programs. DATES: The NTP BSC meeting will be held on December 6, 2007. The deadlines for submission of written comments and for pre-registration for the meeting are November 21 and November 29, 2007, respectively. Persons needing special assistance, such as sign language interpretation or other reasonable accommodation in order to attend, should contact 919-541-2475 (voice), 919-541-4644 TTY (text telephone), through the Federal TTY Relay System at 800-877-8339, or by e-mail to *niehsoeeo@niehs.nih.gov* . Requests should be made at least 7 days in advance of the event. ADDRESSES: The NTP BSC meeting will be held in the Rodbell Auditorium, Rall Building at the NIEHS, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709. Public comments and any other correspondence should be submitted to Dr. Barbara Shane, Executive Secretary for the NTP BSC (NTP Liaison and Scientific Review Office, NIEHS, P.O. Box 12233, MD A3-01, Research Triangle Park, NC 27709; fax: 919-541-0295; or e-mail: *shane@niehs.nih.gov* ). FOR FURTHER INFORMATION CONTACT: Dr. Barbara Shane (telephone: 919-541-4253 or e-mail: *shane@niehs.nih.gov* ). SUPPLEMENTARY INFORMATION: Preliminary Agenda Topics and Availability of Meeting Materials Preliminary agenda topics include: • Update of NTP activities • NTP study plans for mold • Review of NTP study nominations and proposed research and testing activities: aminopyridines, diethyl phthalate, 2-methoxy-4-nitroaniline, nanoscale gold, 2′,2′-dithiobisbenzanilide, and pentaethylenehexamine. The BSC will discuss research concepts for aminopyridines, diethyl phthalate, 2-methoxy-4-nitroaniline, and nanoscale gold. In addition, they will provide comment on a research concept for a phthalates initiative. • Report of the Technical Reports Review Subcommittee meeting held May 16-17, 2007 • Center for the Evaluation of Risks to Human Reproduction nominations: lead and cadmium • Update on process and timelines for the Report on Carcinogens • Implementation of workshop and NTP retreat recommendations A copy of the preliminary agenda, committee roster, draft NTP research concepts, and any additional information when available, will be posted on the NTP Web site ( *http://ntp.niehs.nih.gov/go/165* ) or may be requested in hardcopy from the Executive Secretary for the NTP BSC (see ADDRESSES above). Following the meeting, summary minutes will be prepared and made available on the NTP Web site. Attendance and Registration The meeting is scheduled for December 6, 2007, from 8:30 a.m. to adjournment and is open to the public with attendance limited only by the space available. Individuals who plan to attend are encouraged to register online at the NTP website by November 29, 2007, to facilitate planning for the meeting. Please note that a photo ID is required to access the NIEHS campus. The NTP is making plans to videocast the meeting through the Internet at *http://www.niehs.nih.gov/news/video/index.cfm* . Request for Comments Time is allotted during the meeting for the public to present comments to the NTP BSC on the agenda topics. Each organization is allowed one time slot per agenda topic. At least 7 minutes will be allotted to each speaker, and if time permits, may be extended to 10 minutes at the discretion of the NTP BSC chair. Registration for oral comments will also be available on-site, although time allowed for presentation by on-site registrants may be less than that for pre-registered speakers and will be determined by the number of persons who register at the meeting. Persons registering to make oral comments are asked, if possible, to send a copy of their statement to the Executive Secretary for the NTP BSC (see ADDRESSES above) by November 21, 2007, to enable review by the NTP BSC prior to the meeting. Written statements can supplement and may expand the oral presentation. If registering on-site and reading from written text, please bring 40 copies of the statement for distribution to the NTP BSC and NIEHS/NTP staff and to supplement the record. Written comments received in response to this notice will be posted on the NTP Web site and persons identified by their name and affiliation and/or sponsoring organization, if applicable. Persons submitting written comments should include their name, affiliation (if applicable), phone, e-mail, and sponsoring organization (if any) with the document. Public comments submitted on NTP study nominations in response to a March 29, 2007, **Federal Register** notice (72 FR 14816) are posted on the NTP Web site ( *http://ntp.niehs.nih.gov/go/29306* ). These submissions will be part of the materials provided to the BSC and do not need to be resubmitted. Background Information on the NTP Board of Scientific Counselors The NTP BSC is a technical advisory body comprised of scientists from the public and private sectors that provides primary scientific oversight to the overall program and its centers. Specifically, the NTP BSC advises the NTP on matters of scientific program content, both present and future, and conducts periodic review of the program for the purpose of determining and advising on the scientific merit of its activities and their overall scientific quality. Its members are selected from recognized authorities knowledgeable in fields such as toxicology, pharmacology, pathology, biochemistry, epidemiology, risk assessment, carcinogenesis, mutagenesis, molecular biology, behavioral toxicology, neurotoxicology, immunotoxicology, reproductive toxicology or teratology, and biostatistics. Members serve overlapping terms of up to four years. NTP BSC meetings are held annually or biannually. Dated: October 10, 2007. Samuel H. Wilson, Acting Director, National Institute of Environmental Health Sciences and National Toxicology Program. [FR Doc. E7-20519 Filed 10-16-07; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the President's Council on Physical Fitness and Sports AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services

(DHHS)is hereby giving notice that the President's Council on Physical Fitness and Sports will hold a meeting. This meeting is open to the public. A description of the Council's functions is included also with this notice. DATES: November 7, 2007, from 8 a.m. to 3 p.m. ADDRESSES: Mayo Clinic, Dan Abraham Healthy Living Center, Subway Level, Room 200, 200 First Street, SW., Rochester, Minnesota 55905. FOR FURTHER INFORMATION CONTACT: Melissa Johnson, Executive Director, President's Council on Physical Fitness and Sports, 200 Independence Avenue, Room 738H, SW., Washington, DC 20201,

(202)690-5187. SUPPLEMENTARY INFORMATION: The President's Council on Physical Fitness and Sports (PCPFS) was established originally by Executive Order 10673, dated July 16, 1956. PCPFS was established by President Eisenhower after published reports indicated that American boys and girls were unfit compared to the children of Western Europe. Authorization to continue Council operations was given at appropriate intervals by subsequent Executive Orders. The Council has undergone two name changes and several reorganizations. Presently, the PCPFS is a program office located organizationally in the Office of Public Health and Science within the Office of the Secretary in the U.S. Department of Health and Human Services. On September 28, 2007, President Bush signed Executive Order 13265 to reestablish the PCPFS. Executive Order 13265 was established to expand the focus of the Council. This directive instructed the Secretary to develop and coordinate a national program to enhance physical activity and sports participation. The Council currently operates under the stipulations of the new directive. The primary functions of the Council include:

(1)To advise the President, through the Secretary, on the progress made in carrying out the provisions of the enacted directive and recommend actions to accelerate progress;

(2)to advise the Secretary on ways and means to enhance opportunities for participation in physical fitness and sports and, where possible, to promote and assist in the facilitation and/or implementation of such measures;

(3)to advise the Secretary regarding opportunities to extend and improve physical activity/fitness and sports programs and services at the national, State, and local levels; and

(4)to monitor the need for the enhancement of programs and educational and promotional materials sponsored, overseen, or disseminated by the Council and advise the Secretary, as necessary, concerning such needs. The PCPFS holds at a minimum, one meeting in the calendar year to

(1)Assess ongoing Council activities and

(2)discuss and plan future projects and programs. Dated: October 10, 2007. Melissa Johnson, Executive Director, President's Council on Physical Fitness and Sports. [FR Doc. E7-20473 Filed 10-16-07; 8:45 am] BILLING CODE 4150-35-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Establishment Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Secretary, Department of Health and Human Services (HHS), announces the establishment of the Board of Scientific Counselors, National Center for Public Health Informatics (NCPHI). This board is established to ensure that the national center has access to external viewpoints, the capacity to conduct peer review of scientific programs, and perform second level peer-review of research applications. The Board of Scientific Counselors, NCPHI will advise the Secretary, HHS; and the Director, Centers for Disease Control and Prevention; concerning strategies and goals for the programs and research within the national centers; shall conduct peer-review of scientific programs; and monitor the overall strategic direction and focus of the national centers. The board, after conducting its periodic reviews, shall submit a written description of the results of the review and its recommendations to the Director, CDC. The board shall also perform second-level peer review of applications for grants-in-aid for research and research training activities, cooperative agreements, and research contract proposals relating to the broad areas within the national centers. For information, contact Dr. Tom Savel, Executive Secretary, Centers for Disease Control and Prevention, of the Department of Health and Human Services, 1600 Clifton Road, NE., Mailstop E78, Atlanta, Georgia 30333, telephone 404/498-3081 or fax 404/498-6570. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 9, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E7-20475 Filed 10-16-07; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS-5045-N] Medicare Program: Medicare Clinical Laboratory Services Competitive Bidding Demonstration Project AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. SUMMARY: This notice announces the first demonstration site for the Medicare Clinical Laboratory Services Competitive Bidding Demonstration project and the date for the Bidder's Conference. The Medicare Clinical Laboratory Competitive Bidding Demonstration was mandated by the Congress. Section 302(b) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

(MMA)(Pub. L. 108-173) requires the Centers for Medicare & Medicaid Services

(CMS)to conduct a demonstration project on the application of competitive acquisition for clinical laboratory services that would otherwise be paid under the Medicare Part B fee schedule. The objective of the demonstration is to determine whether competitive bidding can be used to provide Part B clinical laboratory services at fees below current Medicare payment rates while maintaining quality and access to care. The MMA specifically requires that the demonstration:

(1)Includes tests paid under the Medicare Part B Clinical Laboratory Fee Schedule;

(2)excludes entities that have a “face-to-face encounter” with the patient;

(3)excludes Pap smears and colorectal cancer screening tests; and,

(4)includes requirements under the Clinical Laboratory Improvement Amendments

(CLIA)program. An initial Report to the Congress was submitted April 2006. *Site(S):* The fundamental criteria for selecting demonstration sites require that each Metropolitan Statistical Area

(MSA)allows for potential Medicare program savings from the demonstration, is administratively feasible, represents the laboratory market, and will yield demonstration results that can be generalized to other MSAs. The first demonstration site will be the San Diego-Carlsbad-San Marcos, California MSA. A Bidders Conference is planned for October 31, 2007 in the San Diego-Carlsbad-San Marcos, California MSA. The demonstration covers tests provided to beneficiaries enrolled in the traditional fee-for-service

(FFS)Medicare program who reside in the area of the demonstration site or competitive bid area

(CBA)during the 3 year demonstration period. Beneficiaries who travel outside the CBA during the demonstration period and require laboratory services will be able to access services from most laboratories in the United States. We will not directly pay, however, for services furnished by a required bidder that did not bid or bid and did not win or a non-required bidder that bid and did not win. (The terms “required bidder” and “non-required bidder” are explained in section II below.) Laboratories may not bill beneficiaries for laboratory services covered under the Medicare program. FOR FURTHER INFORMATION CONTACT: Linda Lebovic at

(410)786-3402 or *lab_ bid _demo@cms. hhs.gov* . Interested parties can obtain information about the demonstration project on the CMS Web site at *http://www.cms.hhs.gov/ DemoProjectsEvalRpts/ downloads/2004_Demonstration_ Competitive_ Bidding_ Clinical_ Laboratory_ Services.pdf.* SUPPLEMENTARY INFORMATION: I. Background Section 302(b) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

(MMA)(Pub. L. 108-173) amends section 1847(e) of the Social Security Act (the Act) (42 U.S.C. 1395w-3) —“Competitive Acquisition of Certain Items and Services,” to include a demonstration project for clinical laboratory services. The statute requires the Secretary of Health and Human Services to conduct a demonstration project on the application of competitive acquisition for payment of clinical laboratory services that would otherwise be made under Medicare Part B Clinical Laboratory Fee Schedule. II. Provisions of the Notice Under section 1847(e) of the Act, Pap smears and colorectal cancer screening tests are excluded from this demonstration. Requirements under CLIA as mandated in section 353 of the Public Health Service Act apply. The aggregate amounts to be paid to contractors in a competitive acquisition area are expected to be less than the aggregate amounts that would otherwise be paid under the laboratory fee schedule. The payment basis determined for each competitive acquisition area will be substituted for payment under the existing Medicare Part B Clinical Laboratory Fee Schedule. The demonstration period is 3 years for each demonstration site or “competitive bid area” (CBA). The competitively set demonstration fee schedule will be used to pay for laboratory services in the CBA for the duration of the 3-year demonstration period. Multiple winners are expected in each CBA. *Required bidders* are defined as those organizations that will supply, or expect to supply, at least $100,000 annually in demonstration tests to Medicare beneficiaries residing in the CBA during any year of the demonstration. Required bidders that bid and win will be paid under one demonstration fee schedule for services provided to beneficiaries residing in the CBA for the duration of the demonstration. *Non-required bidders* are defined as laboratories that are not exempt from the demonstration, but have the option of participating in the bidding process. Non-required bidders that do not bid as well as those that bid and win, will be paid under the demonstration fee schedule for the duration of the demonstration. These laboratories will be paid under the same fee schedule as the winning required bidders. Non-required bidders that choose to bid and do not win will not receive payment for services provided to beneficiaries residing in the CBA for the duration of the demonstration period. A non-required bidder is: • A small business laboratory, which we are defining as one that will supply less than $100,000 annually in demonstration tests to Medicare FFS beneficiaries residing in the CBA during each year of the demonstration. These laboratories may choose to be a “passive” laboratory. A passive-small business laboratory will have a $100,000 ceiling on annual payment from Medicare for demonstration tests for the duration of the demonstration. • A laboratory that exclusively serves beneficiaries entitled to Medicare because they have end-stage renal disease

(ESRD)residing in the CBA may choose to be a “passive” laboratory under the demonstration. A passive-ESRD laboratory may continue to provide services to ESRD beneficiaries residing in the CBA and receive payment from Medicare for demonstration tests paid under the competitively set Part B Clinical Laboratory Fee Schedule (demonstration fee schedule) for the duration of the demonstration. • A laboratory that exclusively serves beneficiaries residing in nursing homes or receiving home health services in the CBA may choose to be a “passive” laboratory under the demonstration. A passive-nursing home laboratory may continue to provide services to beneficiaries residing in nursing homes or receiving home health services in the CBA and receive payment from Medicare for demonstration tests paid under the demonstration fee schedule for the duration of the demonstration. This notice announces a “Bidder's Conference” to be held in the San Diego-Carlsbad-San Marcos, California MSA on October 31, 2007 for potential bidders to learn about the demonstration rules and ask questions about the bidding process. A Bidder's Package provides information about the demonstration project and is available to the public on the CMS project Web site. There will be a single bidding competition covering demonstration tests for each CBA. Bidders will be required to submit a bid price for each Health Care Procedure Coding System (HCPCS) code in the demonstration test menu. Bidding laboratories will be asked to identify demonstration tests that they do not perform, and will be asked to explain their plans for responding to requests for demonstration tests that they do not perform in house (for example, subcontracting and referrals). As part of their bid, laboratories will provide information on ownership, location of affiliated laboratories and specimen collection sites, CLIA certification, laboratory finances, and quality. III. Collection of Information Requirements This information collection requirement is subject to the Paperwork Reduction Act of 1995 (PRA). The collection is currently approved under OMB control number 0938-1008 entitled “Medicare Clinical Laboratory Services Competitive Bidding Demonstration Project Application Form” with a current expiration date of January 31, 2009. Authority: Section 302(b) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). (Catalog of Federal Domestic Assistance Program No. 93.773 Medicare—Hospital Insurance Program; and No. 93.774, Medicare—Supplementary Medical Insurance Program) Dated: October 4, 2007. Kerry Weems, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. E7-20499 Filed 10-16-07; 8:45 am] BILLING CODE 4120-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, Public Health Service, HHS. ACTION: Notice. SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804; telephone: 301/496-7057; fax: 301/402-0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. Novel Roles of a DNA Repair Protein, DNA-PKcs, in Obesity, Neurological Function, and Aging *Description of Technology:* The catalytic subunit of the DNA-dependent protein kinase complex (DNA-PKcs) has been shown to be important in DNA repair and VDJ recombination in lymphocytes. The inventors have discovered that DNA-PKcs also plays novel, important roles in energy regulation and neurological function. The inventors observed that mature DNA-PKcs-deficient mice (also known as SCID mice) have a lower proportion of fat, resist obesity, and have significantly greater physical endurance than wild-type control mice, particularly with increasing age. The inventors also observed that DNA-PKcs-deficient mice have better memory and less anxiety. One potential explanation for this is that they express higher levels of brain-derived neurotrophic factor (BDNF), which is associated with neurogenesis, memory formation and suppression of anxiety and depression. Moreover, DNA-PKcs-deficient cells produce less oxidative stress. Thus, inhibition of DNA-PKcs may have unexpected utility in the treatment of a wide range of diseases and conditions. The invention discloses methods of inhibiting DNA-PKcs activity to decrease adiposity, improve physical endurance and increase insulin sensitivity and the number of mitochondria. Also claimed are methods directed to improved neurological function, such as methods for protection from neurodegenerative disease, improving memory and learning ability, and for reducing depression and anxiety. Additionally, the invention discloses methods for reducing inflammation and for treating heart disease. *Applications:* Development of therapeutics targeting obesity, insulin-resistant diabetes, and age-related loss of physical endurance. Development of therapeutics to treat neurological disorders such as depression and memory loss. *Market:* Obesity is a large and growing therapeutic market; over thirty percent of Americans are obese, and over sixty percent are overweight. Similarly, the market for therapeutics directed to insulin-resistant, or Type 2, diabetes is rapidly expanding; the market for such drugs is expected to top $12 billion in 2012. Loss of endurance and muscle mass is common in the elderly; the average adult loses thirty percent of his muscle mass between the ages of 20 and 70. *Development Status:* Early stage. *Inventors:* Jay H. Chung et al. (NHLBI). *Publication:* In preparation. *Patent Status:* U.S. Provisional Application No. 60/958,714 filed 06 July 2007 (HHS Reference No. E-068-2007/0-US-01). *Licensing Status:* This technology is available for exclusive, co-exclusive, or nonexclusive licensing. *Licensing Contact:* Tara L. Kirby, Ph.D.; 301/435-4426; *tarak@mail.nih.gov* . *Collaborative Research Opportunity:* The National Heart Lung and Blood Institute, Laboratory of Biochemical Genetics, is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize DNA-PKcs inhibitors for treatment or prevention of metabolic and degenerative diseases. Please contact Jay Chung ( *chungj@nhlbi.nih.gov* ) for more information. Predictive Diagnostic Test for Anti-Depressant Related Suicide Risk *Description of Technology:* A number of studies have reported a potential link between antidepressant treatment and suicides. Although the scientific basis for this phenomenon is not known, the Food and Drug Administration

(FDA)required a black box warning of worsening depression and/or emergence of suicidality (i.e., development of suicidal thoughts or behavior) in both adult and pediatric patients taking several antidepressants. While use of antidepressants fell subsequent to the black box warning, recent studies suggest that pediatric suicides may actually be rising. This has led to concerns that untreated depression due to the black box warning could potentially result in an overall increase in suicides. To determine whether a genetic basis for suicidal risk exists for a sub-group of depressed patients, NIH researchers genetically screened patients with major depression treated with the serotonin selective reuptake inhibitor

(SSRI)citalopram (Celexa) in the NIMH-funded Sequenced Treatment Alternatives for Depression (STAR*D) trial. Versions of two genes coding for components of the brain's glutamate chemical messenger system were linked to suicidal thinking associated with antidepressant use. Having both implicated versions increased risk of such thoughts more than 14-fold. By identifying those patients who need close monitoring, alternative treatments and/or specialty care, these genetic tests should prevent the under prescribing of anti-depressant drugs and the resulting possibility of suicide due to sub-optimal treatment. *Applications:* Diagnostic tests predicting the likelihood of suicide during anti-depressant treatment. *Market:* Depression ranks among the ten leading causes of disability and will become the second-largest cause of the global health burden by 2020. An estimated 121 million people worldwide suffer from a depressive disorder for which they require treatment. It is estimated that 5.8% of all men and 9.5% of all women will suffer from a depressive disorder in any given year and that 17% of all men and women will suffer from a depressive disorder at some point in their lives. *Development Status:* Clinical data. *Inventors:* Francis J. McMahon et al. (NIMH). *Patent Status:* U.S. Provisional Application No. 60/854,978 Filed 27 Oct 2006 (HHS Reference No. E-157-2006/0-US-01). *Licensing Status:* Available for licensing. *Licensing Contact:* Norbert Pontzer, Ph.D., J.D.; 301/435-5502; *pontzern@mail.nih.gov* . *Collaborative Research Opportunity:* The National Institute of Mental Health Mood and Anxiety Disorders Program Genetics Unit is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the Predictive Diagnostic Test for Anti-Depressant Related Suicide. Please contact Dr. Francis McMahon at *mcmahonf@mail.nih.gov* for more information. Dated: October 11, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7-20483 Filed 10-16-07; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, Public Health Service, HHS. ACTION: Notice. SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804; telephone: 301/496-7057; fax: 301/402-0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. HIV-1 Integrase Inhibitors for the Treatment of Retroviral Infections *Description of Technology* : This technology describes the structure and activity of N-benzyl derivatives of 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 2,3-dihydro-6,7-dihydroxy-1H-isoindole-1,3(2H)-diones as new HIV-1 integrase inhibitors. HIV, as well as other retroviruses, requires three key viral enzymes for replication: Reverse transcriptase, protease and integrase (IN). A significant number of patients fail to respond to combination therapies consisting of reverse transcriptase and protease inhibitors, due to the development of viral resistance. IN functions by initial processing of viral cDNA in a cleavage step termed 3′-processing (3′-P). This is followed by insertion of the cleaved cDNA into the host genome in a reaction known as “strand transfer” (ST). Certain agents covered under the subject technology have been shown to exhibit selective inhibition of ST reactions relative to 3′-P reactions. These compounds inhibit purified IN *in vitro* and are also active against HIV-1 derived vectors in cell-based assay. These inhibitors may have a potential therapeutic value for retroviral infections, including AIDS, especially for patients exhibiting drug resistance to current therapy regimes. *Applications:* The treatment and prevention of HIV infections. *Development Status: In vitro* data available. *Inventors:* Terrence R. Burke Jr., Xue Zhi Zhao, Yves Pommier, and Elena Semenova (NCI). *Related Publication:* WG Verschueren et al. Design and optimization of tricyclic phtalimide analogue as novel inhibitors of HIV-1 integrase. J Med Chem 2005 Mar 24;48(6):1930-1940. *Patent Status* : U.S. Provisional Application No. 60/956,636 filed 17 Aug 2007 (HHS Reference No. E-237-2007/0-US-01). *Licensing Status:* Available for licensing. *Licensing Contact:* Sally Hu, Ph.D., M.B.A.; 301/435-5606; *HuS@mail.nih.gov* . *Collaborative Research Opportunity:* The National Cancer Institute's Laboratory of Medicinal Chemistry and Laboratory of Molecular Pharmacology are seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the HIV-1 integrase inhibitors described. Please contact John D. Hewes, Ph.D. at 301-435-3121 or *hewesj@mail.nih.gov* for more information. Thiazepine Inhibitors of HIV-1 Integrase *Description of Technology:* The human immunodeficiency virus

(HIV)is the causative agent of acquired immunodeficiency syndrome (AIDS). Drug-resistance is a critical factor contributing to the gradual loss of clinical benefit to treatments for HIV infection. Accordingly, combination therapies have further evolved to address the mutating resistance of HIV. However, there has been great concern regarding the apparent growing resistance of HIV strains to current therapies. It has been found that a certain class of compounds including thiazepines and analogs and derivatives thereof are effective and selective anti-integrase inhibitors. These compounds have been found to inhibit both viral replication and the activity of purified HIV-1 integrase. The subject invention provides for such compounds and for methods of inhibiting HIV integrase. *Inventors:* Yves Pommier et al. (NCI). *Patent Status:* U.S. Patent No. 7,015,212 issued 21 Mar 2006 (HHS Reference No. E-036-1999/0-US-03). *Licensing Status:* Available for exclusive or non-exclusive licensing. *Licensing Contact:* Sally Hu, Ph.D., M.B.A.; 301/435-5606; *HuS@mail.nih.gov.* *Collaborative Research Opportunity:* The Laboratory of Molecular Pharmacology of the National Cancer Institute is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize anti-integrase inhibitors. Please contact John D. Hewes, Ph.D. at 301-435-3121 or *hewesj@mail.nih.gov* for more information. Quinoline Inhibitors of Retroviral Integrase *Description of Technology:* The subject invention describes certain diketo quinolin-4-1 derivatives and their use as integrase inhibitors in the treatment of HIV infection. The results of *in vitro* integrase inhibition studies show that these derivatives have significant anti-integrase activity (e.g., an IC50 for strand transfer inhibition of not greater than 2 μM). Thus, these derivatives might be potentially important lead compounds for the development of integrase inhibitors. Since HIV integrase is an essential enzyme for effective viral replication, the development of such inhibitors of HIV integrase would thus potentially be useful and effective in the treatment of HIV infection. *Inventors:* Yves Pommier et al. (NCI). *Patent Status* : U.S. Patent Application No. 10/591,679 filed 01 Sep 2006, claiming priority to 10 Mar 2004 (HHS Reference No. E-187-2003/0-US-01). *Licensing Contact:* Sally Hu, Ph.D., M.B.A.; 301/435-5606; *HuS@mail.nih.gov* . Discovery of Tropolone Inhibitors of HIV-1 Integrase that can be Used for the Treatment of Retroviral Infection, Including AIDS *Description of Technology:* This invention provides pharmaceutical compositions comprising one or more HIV-1 integrase inhibitor compounds, as well as methods for treatment or prevention of HIV infection. These compounds are alpha-hydroxytropolone or its salt, solvate or hydrate, and they have been shown to inhibit the integrase by interfering with the enzyme catalytic site by chelating magnesium ions, and have been shown to inhibit the strand transfer reaction. Integrase is an important target for AIDS therapy since it is critical for viral replication, and does not have cellular counterparts, which can potentially reduce toxic side effects. Thus, the compounds of this invention can be developed as novel anti-viral agents that can be used in combinational therapy, especially since they might be less toxic than other anti-viral agents. In addition to licensing, the technology is available for further development through collaborative research opportunities with the inventors. *Inventors:* Yves Pommier et al. (NCI). *Patent Status:* PCT Application No. PCT/US2006/046259 filed 01 Dec 2006, which published as WO 2007/065007 on 06 Jul 2007 (HHS Reference No. E-308-2005/0-PCT-02). *Licensing Contact:* Sally Hu, Ph.D., M.B.A.; 301/435-5606; *HuS@mail.nih.gov* . Integrase Inhibitors for the Treatment of Retroviral Infection Including Human Immunodeficiency Virus-1 *Description of Technology:* Available for licensing and commercial development are stilbenedisulfonic acid derivatives for treatment of human immunodeficiency virus-1 (HIV-1) and other retroviral infections. Current HIV-1 therapeutic treatments target the viral protease and reverse transcriptase enzymes, which are essential for retroviral infection. However, these drugs often have limitations due to drug resistant variants, which render drugs ineffective. Additionally, such drugs are often toxic when administered in combination therapies. Thus, efficacious inhibitors of retroviral infection that are devoid of toxicity are presently needed. The subject invention describes stilbenedisulfonic acid derivatives, which target the integrase enzyme of retroviruses. Similar to protease and reverse transcriptase activity, integrase function is essential for retroviral infection. Integrase catalyzes integration of reverse transcribed viral DNA into a host cell's genome. For this reason, integrase is considered a rational therapeutic target for HIV-1 infection. Further, integrase is a favorable target because the enzyme has no human cellular counterpart, which could interact with a potential integrase inhibitor and cause harmful side effects. Recent clinical data with an integrase inhibitor from Merck shows impressive clinical activity. The Merck compound is different from the current invention and is projected for FDA approval mid 2007. Thus, the subject invention is valuable for safe and effective treatment of HIV-1 and other retroviral infections. *Application:* Treatment of HIV infection. *Development Status* : The technology is ready for use in drug discovery and development. *Inventors:* Yves Pommier (NCI), Elena Semenova (NCI), Christophe Marchand (NCI). *Patent Status:* U.S. Provisional Application No. 60/849,718 filed 04 Oct 2006 (HHS Reference No. E-264-2006/0-US-01). *Licensing Status:* Available for exclusive or non-exclusive licensing. *Licensing Contact:* Sally Hu, Ph.D., M.B.A.; 301/435-5606; *HuS@mail.nih.gov* . Dated: October 10, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7-20513 Filed 10-16-07; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, Public Health Service, HHS. ACTION: Notice. SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804; telephone: 301/496-7057; fax: 301/402-0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. Alpha 1-3 N-Acetylgalactosaminyltransferases With Altered Donor and Acceptor Specificities, Compositions, and Methods of Use *Description of Invention:* The present invention relates to the field of glycobiology, specifically to glycosyltransferases. The present invention provides structure-based design of novel glycosyltransferases and their biological applications. The structural information of glycosyltransferases has revealed that the specificity of the sugar donor in these enzymes is determined by a few residues in the sugar-nucleotide binding pocket of the enzyme, which is conserved among the family members from different species. This conservation has made it possible to reengineer the existing glycosyltransferases with broader sugar donor specificities. Mutation of these residues generates novel glycosyltransferases that can transfer a sugar residue with a chemically reactive functional group to N-acetylglucosarnine (GlcNAc), galactose

(Gal)and xylose residues of glycoproteins, glycolipids and proteoglycans (glycoconjugates). Thus, there is potential to develop mutant glycosyltransferases to produce glycoconjugates carrying sugar moieties with reactive groups that can be used in the assembly of bio-nanoparticles to develop targeted-drug delivery systems or contrast agents for medical uses. Accordingly, methods to synthesize N-acetylglucosamine linkages have many applications in research and medicine, including in the development of pharmaceutical agents and improved vaccines that can be used to treat disease. This application claims compositions and methods based on the structure-based design of alpha 1-3 N-Acetylgalactosaminyltransferase (alpha 3 GalNAc-T) mutants from alpha 1-3galactosyltransferase (a3Gal-T) that can transfer 2′-modified galactose from the corresponding UDP-derivatives due to mutations that broaden the alpha 3Gal-T donor specificity and make the enzyme alpha3 GalNAc-T. *Application:* Development of pharmaceutical agents and improved vaccines. *Developmental Status:* Enzymes have been synthesized and preclinical studies have been performed. *Inventors:* Pradman Qasba, Boopathy Ramakrishnan, Elizabeth Boeggman, Marta Pasek (NCI). *Patent Status:* PCT Patent Application filed 22 Aug 2007 (HHS Reference No. E-279-2007/0-PCT-01). *Licensing Status:* Available for exclusive or non-exclusive licensing. *Licensing Contact:* Peter A. Soukas, J.D.; 301/435-4646; *soukasp@mail.nih.gov* . *Collaborative Research Opportunity:* The National Cancer Institute's Nanobiology Program is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize structure-based design of novel glycosyltransferases. Please contact John D. Hewes, Ph.D. at 301-435-3121 or *hewesj@mail.nih.gov* for more information. Beta 1,4-Galactosyltransferases With Altered Donor and Acceptor Specificities, Compositions and Methods of Use *Description of Invention:* The present invention relates to the field of glycobiology, specifically to glycosyltransferases. The present invention provides structure-based design of novel glycosyltransferases and their biological applications. The structural information of glycosyltransferases has revealed that the specificity of the sugar donor in these enzymes is determined by a few residues in the sugar-nucleotide binding pocket of the enzyme, which is conserved among the family members from different species. This conservation has made it possible to reengineer the existing glycosyltransferases with broader sugar donor specificities. Mutation of these residues generates novel glycosyltransferases that can transfer a sugar residue with a chemically reactive functional group to N-acetylglucosarnine (GlcNAc), galactose

(Gal)and xylose residues of glycoproteins, glycolipids and proteoglycans (glycoconjugates). Thus, there is potential to develop mutant glycosyltransferases to produce glycoconjugates carrying sugar moieties with reactive groups that can be used in the assembly of bio-nanoparticles to develop targeted-drug delivery systems or contrast agents for medical uses. Accordingly, methods to synthesize N-acetylglucosamine linkages have many applications in research and medicine, including in the development of pharmaceutical agents and improved vaccines that can be used to treat disease. The invention claims beta (1,4)-galactosyltransferase I mutants having altered donor and acceptor and metal ion specificities, and methods of use thereof. In addition, the invention claims methods for synthesizing oligosaccharides using the beta (1,4)-galactosyltransferase I mutants and to using the beta (1,4)-galactosyltransferase I mutants to conjugate agents, such as therapeutic agents or diagnostic agents, to acceptor molecules. More specifically, the invention claims a double mutant beta 1,4 galactosyltransferase, human beta-1,4-Tyr289Leu-Met344His-Gal-T1, constructed from the individual mutants, Tyr289Leu-Gal-T1 and Met344His-Gal-T1, that transfers modified galactose in the presence of magnesium ion, in contrast to the wild-type enzyme which requires manganese ion. *Application:* Development of pharmaceutical agents and improved vaccines. *Developmental Status:* Enzymes have been synthesized and preclinical studies have been performed. *Inventors:* Pradman Qasba, Boopathy Ramakrishnan, Elizabeth Boeggman (NCI). *Patent Status:* PCT Patent Application filed 22 Aug 2007 (HHS Reference No. E-280-2007/0-PCT-01). *Licensing Status:* Available for exclusive or non-exclusive licensing. *Licensing Contact:* Peter A. Soukas, J.D.; 301/435-4646; *soukasp@mail.nih.gov* *Collaborative Research Opportunity:* The CCR Nanobiology Program of the National Cancer Institute is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize glycosyltransferases. Please contact John D. Hewes, Ph.D., Technology Transfer Specialist, NCI, at

(301)435-3121 or *hewesj@nail.nih.gov.* Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections *Description of Invention:* Over the past decade, *Staphylococcus epidermidis* has become the most prevalent pathogen involved in nosocomial infections. Usually an innocuous commensal microorganism on human skin, this member of the coagulase-negative group of staphylococci can cause severe infection after penetration of the epidermal protective barriers of the human body. In the U.S. alone, *S. epidermidis* infections on in-dwelling medical devices, which represent the main type of infection with *S. epidermidis* , cost the public health system approximately $1 billion per year. Importantly, *S. epidermidis* is frequently resistant to common antibiotics. Immunogenic compositions and methods for eliciting an immune response against *S. epidermidis* and other related staphylococci are claimed. The immunogenic compositions can include immunogenic conjugates of poly-γ-glutamic acid (such as γDLPGA) polypeptides of *S. epidermidis* , or related staphylococci that express a γPGA polypeptide. The γPGA conjugates elicit an effective immune response against *S. epidermidis* , or other staphylococci, in subjects to which the conjugates are administered. A method of treating an infection caused by a *Staphylococcus* organism that expresses *cap* genes is also disclosed. The method can include selecting a subject who is at risk of or has been diagnosed with the infection by the *Staphylococcus* organism which expresses γPGA from the *cap* genes. Further, the expression of a γPGA polypeptide by the organism can then be altered. *Application:* Prophylactics against *S. epidermidis* . *Developmental Status:* Preclinical studies have been performed. *Inventors:* Michael Otto, Stanislava Kocianova, Cuong Vuong, Jovanka Voyich, Yufeng Yao, Frank DeLeo (NIAID) *Publication:* S Kocianova *et al.* Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of *Staphylococcus epidermidis.* J Clin Invest. 2005 Mar;115(3):688-694. *Patent Status:* PCT Patent Application No. PCT/US2006/026900 filed 10 Jul 2006 (HHS Reference No. E-263-2005/0-PCT-02). *Licensing Status:* Available for exclusive or non-exclusive licensing. *Licensing Contact:* Peter A. Soukas, J.D.; 301/435-4646; soukasp@mail.nih.gov *Collaborative Research Opportunity:* The National Institute of Allergy and Infectious Diseases, Laboratory of Human Bacterial Pathogenesis, is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the use of poly-γ-glutamic acid of staphylococci. Please contact Dr. Michael Otto at *motto@niaid.nih.gov* for more information. Dated: October 10, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7-20515 Filed 10-16-07; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, Public Health Service, HHS. ACTION: Notice. SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804; telephone: 301/496-7057; fax: 301/402-0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. Multiple Donor Tissue-Derived Large IgM VH-Based F ab Human Antibody Library *Description of Technology:* Available for licensing as a biological material for either internal use or commercial distribution is a human F ab immunoglobulin/antibody fragment phage display library. The library contains 10 10 F abs derived from the peripheral blood of ten

(10)healthy human donors. The high quality of the library was demonstrated in the successful selection of high affinity antibodies specific for Hendra and Nipah viruses; however, the library is useful for selecting a variety of antigen specific immunoglobulin/antibody F ab fragments especially for cancer or viruses. *Applications:* Antibody discovery—Diagnostics, Therapeutics, Research Reagents. *Advantages and Benefits:* High affinity multi-purpose antibodies. *Inventors:* Dimiter S. Dimitrov

(NCI)et al. *Publications:* 1. Zhang et al. Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning. J Immunol Methods. 2006 Dec 20; 317(1-2):21-30. Epub 2006 Oct 16. 2. Zhu et al. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. J Virol. 2006 Jan;80(2):891-899. 3. Zhang et al. Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS. Curr Opin Mol Ther. 2005 Apr;7(2):151-156. Review. *Patent Status:* HHS Reference No. E-188-2007/0—Research Tool. Patent protection is not being sought for this technology. *Licensing Status:* Available for non-exclusive licensing as biological material. *Licensing Contact:* Michael Shmilovich, Esq.; 301/435-5019; *shmilovm@mail.nih.gov* . *Collaborative Research Opportunity:* The NCI-Frederick is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize therapeutic, diagnostic or research reagent antibodies. Please contact Thomas Stackhouse at *stackhot@mail.nih.gov* or 301-846-5465 for more information. Optical Slice Motion Tracker *Description of Technology:* Available for licensing and commercial development is an apparatus that adjusts the focal plane of a microscope in order to track plane motion of a sample. The apparatus includes a motor that can change the focal plane by moving the objective of the microscope and a computer that reads image data from the microscope photomultiplier tube (PMT). The apparatus uses time between images to perform a navigator function comprising quickly scanning many nearby focal planes with a minimum field of view and utilizing pattern matching to calculate an offset distance to adjust the focal plane. The apparatus permits imaging of moving structures, such as living tissue, over time by compensating for motion in the direction of the focal plane. The use of navigator movement to track an optically selected slice can be implemented in any of various research or medical devices. *Applications:* Microscopy; Cell biology. *Development Status:* Early-stage; Prototype. *Inventors:* James L. Schroeder (NHLBI), Robert S. Balaban (NHLBI), Thomas J. Pohida (CIT), John W. Kakareka (CIT), Randall Pursley (CIT). *Patent Status:* U.S. Provisional Application No. 60/904,683 filed 02 Mar 2007 (HHS Reference No. E-114-2007/0-US-01). The issued and pending patent rights are solely owned by the United States Government. *Licensing Status:* Licensing on a non-exclusive basis and exclusive to qualified applicants whose application for licensure complies with 37 CFR 404. *Licensing Contact:* Michael A. Shmilovich, Esq.; 301/435-5019; *shmilovm@mail.nih.gov.* *Collaborative Research Opportunity:* The NHLBI is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the optical slice motion tracker. Please contact Lili Portilla at 301-594-4273 or via e-mail at *Lilip@nih.gov* for more information. A Fundus Photo-Stimulation System and Method *Description of Technology:* Available for licensing and commercial development is an optical system which permits targeted photo-stimulation of the retina by positioning the stimulus location under visual guidance through a fundus camera. The system is designed to elicit, under direct infra-red visual control of stimulus size and position in the retina, electroretinograms

(ERGs)in response to photo-stimulation from selected regions of the retina, as well as to present small light stimuli to a selected area to explore visual sensitivity properties. For example, the detected ERGs can be the basis for diagnosing or characterizing patient retina with early stage retinal disease versus healthy retina from the opposite eye. The system can be mounted on commercially available fundus cameras that have infra-red capabilities (or would accept infra-red bandpass filtering of their retinal illumination output) and will accept a near IR CCD camera connected to a TV mounted on the photographic-camera port. The optical system can comprise a targeting light path originating from a deep red laser and a stimulus light path originating from a Xenon strobe lamp. Both light paths are brought into collinear alignment by a beam splitter. The light paths are transmitted to the eye through an adjustable turning mirror and a focusing lens. A beam splitter in front of the fundus camera objective lens merges the optical path of the fundus camera with that of the targeting optical path and the stimulus light path. The merged beams are brought to a focus at or close to the lens of the eye. A movable aperture is interposed on the collinear beams and imaged on the retina such that its lateral position and size can be adjusted by the operator to select the retinal area to be photo-stimulated. This arrangement ensures that the stimulating light flashes illuminate the same field as was selected using the deep red targeting laser. This system permits projection of repeatable visible-light flashes with variable size and location onto the retina. *Applications:* Diagnosis of retinal disease; Electroretinograms. *Development Status:* Early-stage; Prototype available. *Inventors:* Paul Smith (ORS), Edward Wellner (ORS), Francisco de Monasterio (NEI). *Patent Status:* U.S. Provisional Application No. 60/935,107 filed 26 Jul 2007 (HHS Reference No. E-279-2006/0-US-01). The pending patent rights are solely owned by the United States Government. *Licensing Status:* Available for licensing and commercialization. Non-exclusive rights are available. Exclusive rights may be available to qualified applicants and are subject to the provisions set forth in 37 CFR 404.7. *Licensing Contact:* Michael A. Shmilovich, Esq.; 301/435-5019; *shmilovm@mail.nih.gov.* *Collaborative Research Opportunity:* The Laboratory of Bioengineering and Physical Science, NIBIB is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the Fundus Photo-Stimulation System and Method. Please contact Dr. Paul Smith at *smithpa@mail.nih.gov* for more information. Dated: October 10, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7-20517 Filed 10-16-07; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, Public Health Service, HHS ACTION: Notice. SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804; telephone: 301/496-7057; fax: 301/402-0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. Method for Inducing T-Cell Proliferation *Description of Technology:* This technology relates to the use of thymic stromal lymphopoietin

(TSLP)to induce CD4+ T cell proliferation. This proliferation could be of particular relevance for patients in whom this cell population has been significantly reduced by HIV/AIDS or other conditions resulting in immunodeficiency. The proliferation of isolated CD4+ T cells can be induced through direct contact with TSLP or a nucleic acid encoding TSLP. The patent application also describes methods of inducing or enhancing an immune response through administration of CD4+ T cells that have been isolated and induced to proliferate using TSLP or a nucleic acid encoding TSLP. TSLPR knockout mice are also described in the patent application and available for licensing through a biological materials license agreement. *Applications:* Immunotherapy. *Development Status:* Animal (mouse) data available. *Inventor:* Warren J. Leonard et al. (NHLBI). *Patent Status:* U.S. Provisional Application No. 60/555,898 filed 23 Mar 2004 (HHS Reference No. E-104-2004/0-US-01); U.S. Utility Application No. 11/762,357 filed 13 June 2007 (HHS Reference No. E-104-2004/1-US-02). *Licensing Status:* Available for licensing. *Licensing Contact:* Susan Ano, Ph.D.; 301/435-5515; *anos@mail.nih.gov.* Retrovirus-Like Particles as Vaccines and Immunogens *Description of Technology:* This technology describes retrovirus-like particles and their production from retroviral constructs in which the gene encoding of all but seven amino acids of the nucleocapsid

(NC)protein was deleted. NC is critical for both genomic RNA packaging into the virion and viral integration into the host cell. Therefore, this deletion functionally eliminates two essential steps in retrovirus replication, thereby resulting in non-infectious retrovirus-like particles that maintain their full complement of antigenic proteins. Furthermore, efficient formation of these particles requires inhibition of the protease enzymatic activity, either by mutation to the protease gene in the construct or by protease inhibitor thereby ensuring the production of non-infectious retrovirus-like particles by altering two independent targets. These particles can be used in vaccines or immunogenic compositions. Specific examples using HIV-1 constructs are given. *Applications:* Retroviral vaccine; Immunogenic compositions. *Development Status:* In vitro data available. *Inventor:* David E. Ott (NCI). *Publications:* 1. DE Ott et al. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant. J Virol. 2003 May;77(10):5547-5556. 2. DE Ott *et al.* Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly. J Virol. 2005 Nov;79(22), 13839-13847. *Patent Status:* U.S. Patent Application No. 11/413,614 filed 27 Apr 2006 (HHS Reference No. E-236-2003/0-US-02). *Licensing Status:* Available for non-exclusive or exclusive licensing. *Licensing Contact:* Susan Ano, Ph.D.; 301/435-5515; *anos@mail.nih.gov.* *Collaborative Research Opportunity:* The NCI, CCR, AIDS Vaccine Program is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize whole retrovirus-like particle vaccines. Please contact John D. Hewes, Ph.D. at 301-435-3121 or *hewesj@mail.nih.gov* for more information. Potent HIV-1 Entry Inhibitors and Immunogens *Description of Technology:* This technology relates to HIV antigenic constructs with flexible, heterologous linkers joining gp120 and gp41. The HIV-1 envelope Glycoprotein

(Env)undergoes conformational changes while driving entry. The inventors developed these constructs to mimic some of the intermediate Env conformations. Tethered molecules of the invention were stable and potently inhibited cell fusion. Both gp120 and gp41 contain epitopes that may be necessary for the immune system to mount a robust and effective immune response to HIV. By connecting the two components, the current invention stabilizes the exposure of conserved epitopes, thereby increasing the chances that antibodies will form that react with these sites. *Applications:* HIV vaccine. *Development Status:* In vitro data available. *Inventors:* Dimiter S. Dimitrov et al. (NCI). *Patent Status:* U.S. Utility Application No. 10/506,651 filed 02 Sept 2004 (HHS Reference No. E-039-2002/0-US-02). *Licensing Status:* Available for exclusive or non-exclusive licensing. *Licensing Contact:* Susan Ano, Ph.D.; 301/435-5515; *anos@mail.nih.gov.* *Collaborative Research Opportunity:* The National Cancer Institute's Nanobiology Program is seeking statements of capability or interest from parties interested in collaborative research to further develop or evaluate immune response constructs. Please contact John D. Hewes, Ph.D. at 301-435-3121 or *hewesj@mail.nih.gov* for more information. Dated: October 10, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7-20518 Filed 10-16-07; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Exclusive License: Adult Human Dental Pulp Stem Cells, Postnatal Stem Cells, and Multipotent Postnatal Stem Cells From Human Periodontal Ligament AGENCY: National Institutes of Health, Public Health Service, HHS. ACTION: Notice. SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of an exclusive license worldwide to practice the invention embodied in United States issued Patent Number 7,052,907 titled: “Adult Human Dental Pulp Stem Cells in vitro and in vivo” referenced at HHS as E-233-2000/0-US-03 and corresponding foreign patent applications, United States Patent Application Number 10/553,633 titled: “Postnatal Stem Cells and Uses Thereof” referenced at HHS as E-018-2003/0-US-02 and corresponding foreign patent applications, United States Patent Application Number 11/433,627 titled: “Multipotent Postnatal Stem Cells from Human Periodontal Ligament” referenced at DHHS as E-033-2004/0-US-03 and corresponding patent applications, to Angioblast Systems, Inc. having a place of business in the state of New York. The field of use may be limited to the following: FDA or similar foreign body approved therapeutic for

(1)regeneration/repair of the periodontal ligament lost from chronic periodontitis,

(2)regeneration/repair of dentin/pulp complex lost during deep carious lesions and

(3)regeneration/repair of neural networks. The United States of America is the assignee of the patent rights in this invention. The territory may be worldwide. DATES: Only written comments and/or application for a license, which are received by the NIH Office of Technology Transfer on or before December 17, 2007 will be considered. ADDRESSES: Requests for a copy of the patent applications, inquiries, comments and other materials relating to the contemplated license should be directed to: Fatima Sayyid, Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804; Telephone:

(301)435-4521; Facsimile:

(301)402-0220; e-mail: *Fatima.Sayyid@nih.hhs.gov* . SUPPLEMENTARY INFORMATION: The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 60 days from the date of this published Notice, NIH receives written evidence and argument that establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Properly filed competing applications for a license filed in response to this notice will be treated as objections to the contemplated license. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. Dated: October 11, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7-20520 Filed 10-16-07; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Exclusive License: Treatment of Proliferative Disorders Using an Unexpected mTOR Kinase Inhibitor AGENCY: National Institutes of Health, Public Health Service, HHS. ACTION: Notice. SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of an exclusive license to practice the invention embodied in PCT patent application PCT/US2004/041265 filed December 9, 2004, entitled: “Methods for Suppressing an Immune Response or Treating a Proliferative Disorder” [HHS Reference Number: E-259-2003/0-PCT-02], to Emiliem, Inc., a Delaware Corporation, having a place of business in Emeryville, California. The field of use may be limited to the use of 2-(4-piperazinyl) substituted 4H-1-benzopyran-4-one compounds, including 2-(4-piperazinyl)-8-phenyl-4H-1-benzopyran-4-one (LY303511), for the treatment of cancer and/or other proliferative disorders not currently licensed, excluding the treatment and prevention of stenosis and restenosis. The United States of America is an assignee of the patent rights in these inventions. DATES: Only written comments and/or application for a license, which are received by the NIH Office of Technology Transfer on or before December 17, 2007 will be considered. ADDRESSES: Requests for a copy of the patent application, inquiries, comments and other materials relating to the contemplated license should be directed to: Susan Carson, D. Phil., Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804; Email: *carsonsu@od.nih.gov;* Telephone:

(301)435-5020; Facsimile:

(301)402-0220. SUPPLEMENTARY INFORMATION: The search for specific kinase inhibitors is an active area of drug development as there is a continued need for effective anti-proliferative therapeutics with acceptable toxicities. The core invention is a novel method of use of one of the 4H-1-benzopyran-4-one derivatives (LY303511) which has been shown to target mTOR and casein kinase 2

(CK2)without affecting PI3K activity (JPET, May 26, 2005, doi: 10.1124/jpet.105.083550). Proof of concept data is available in an *in vivo* human zenograft PC-3 prostate tumor model, without observed toxicity. *In vitro* data suggest that (2-(4-piperazinyl)-8-phenyl-4H-1-benzopyran-4-one and derivatives may be effective in treating inflammatory, autoimmune and other proliferative disorders including restenosis, inflammatory bowel disease and a variety of cancers. Method of use claims are directed to derivatives of 2-(4-piperazinyl)-substituted 4H-1-benzopyran-4-one compounds as anti-proliferative, immunosuppressive, anti-inflammatory, anti-restenosis and anti-neoplastic agents. The prospective exclusive license will be royalty bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 60 days from the date of this published Notice, NIH receives written evidence and argument that establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Properly filed competing applications for a license filed in response to this notice will be treated as objections to the contemplated license. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. Dated: October 10, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7-20516 Filed 10-16-07; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. COTP Corpus Christi 07-085] South Texas Area Maritime Security (STAMS) Committee; Vacancy AGENCY: Coast Guard, DHS. ACTION: Solicitation for membership. SUMMARY: This notice requests individuals interested in serving on the South Texas Area Maritime Security (STAMS) Committee to submit their application for a potential opening on the committee to the Corpus Christi Captain of the Port/Federal Maritime Security Coordinator. DATES: Applications should reach the Corpus Christi Captain of the Port/Federal Maritime Security Coordinator on or before October 30, 2007. ADDRESSES: Requests for membership should be submitted to the Captain of the Port/Federal Maritime Security Coordinator at the following address: Commander, USCG Sector Corpus Christi, 8930 Ocean Drive, Hangar 41, Corpus Christi, Texas 78419. FOR FURTHER INFORMATION CONTACT: Mr. John Zarbock at 361-888-3162 (X501). SUPPLEMENTARY INFORMATION: Authority Section 102 of the Maritime Transportation Security Act

(MTSA)of 2002 (Pub. L. 107-295) added section 70112 to Title 46 of the U.S. Code, and authorized the Secretary of the Department in which the Coast Guard is operating to establish Area Maritime Security Committees for any port area of the United States. (See 33 U.S.C. 1226; 46 U.S.C. 70112(a)(2); 33 CFR 1.05-1, 6.01; Department of Homeland Security Delegation No. 0170.1.) The MTSA includes a provision exempting these Area Maritime Security

(AMS)Committees from the Federal Advisory Committee Act (FACA), 5 U.S.C. App. (Pub. L. 92-436). The South Texas Area Maritime Security (STAMS) Committee assists the Captain of the Port(COTP)/Federal Maritime Security Coordinator

(FMSC)in the review and update of the STAMS Plan for the Corpus Christi Area of Responsibility. Such matters may include, but are not limited to: Identifying critical port infrastructure and operations; Identifying risks (threats, vulnerabilities, and consequences); Determining mitigation strategies and implementation methods; Developing and describing the process to continually evaluate overall port security by considering consequences and vulnerabilities, how they may change over time, and what additional mitigation strategies can be applied; and Providing advice to, and assisting the COTP/FMSC in, reviewing and updating the STAMS Plan. STAMS Committee Membership Applicants should have at least 5 years of experience related to maritime or port security operations. The STAMS Committee has ten members, made up of at least one individual from the Corpus Christi, Rio Grande Valley, Port of Port Lavaca-Point Comfort and Victoria Barge Canal, Port Security Working Groups (PSWG). The Coast Guard has one vacancy. We are seeking individuals interested in representing the Port of Port Lavaca-Point Comfort PSWG area with this solicitation. Applicants may be required to pass an appropriate security background check prior to appointment to the committee. The member's term of office will be for 5 years; however, a member is eligible to serve an additional term of office. Members will not receive any salary or other compensation for their service on the STAMS Committee. In support of the Coast Guard's policy on gender and ethnic diversity, we encourage qualified women and members of minority groups to apply. Request for Applications Those seeking membership are not required to submit formal applications to the local COTP/FMSC. Nevertheless, because we do have an obligation to ensure that a specific number of members have the prerequisite maritime security experience, we encourage the submission of resumes highlighting experience in the maritime and security industries. Dated: September 4, 2007. R.J. Paulison, Captain, U.S. Coast Guard, Corpus Christi Captain of the Port/Federal Maritime Security Coordinator. [FR Doc. E7-20497 Filed 10-16-07; 8:45 am] BILLING CODE 4910-15-P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG-2007-0003] Temporary Relocation of the Coast Guard National Maritime Center

(NMC)AGENCY: Coast Guard, DHS. ACTION: Notice. SUMMARY: The Coast Guard National Maritime Center (NMC), which was located in Arlington, VA, has temporarily relocated to Kearneysville, WV, as part of a planned effort to restructure and centralize the Mariner Licensing and Documentation

(MLD)Program. This notice provides information regarding both the NMC consolidation and the relocated NMC offices. DATES: The temporary office in Kearneysville, WV, became operational on October 1, 2007. No further NMC operations are being carried out in Arlington, VA. In December 2007, the NMC will move to its permanent location in Martinsburg, WV. ADDRESSES: The NMC's temporary address is: Commanding Officer, Coast Guard National Maritime Center, 130 East Burr Blvd., Kearneysville, WV 25430. In December, 2007, the NMC's permanent address will be: Commanding Officer, Coast Guard National Maritime Center, 100 Forbes Drive, Martinsburg, WV 25404. FOR FURTHER INFORMATION CONTACT: If you have questions on this notice, call Mr. Jeffrey Brandt, National Maritime Center, telephone 304-724-9559. SUPPLEMENTARY INFORMATION: The MLD Program restructuring and centralization plan, approved in 2005, will centralize many of the simultaneous efforts of 17 independently operating Regional Examination Centers

(RECs)into one Merchant Mariner Credential

(MMC)processing center in Martinsburg, WV. Having one MMC processing center will allow for more consistent procedures, cost reduction, improved oversight, and improved mariner assistance. The NMC has been reorganized into five divisions consisting of the Operations and Oversight Division (NMC-1), Mariner Training and Assessment Division (NMC-2), Program Support Division (NMC-3), Mariner Records Division (NMC-4), and Mariner Services Division (NMC-5). We have temporarily relocated the NMC to Kearneysville, WV. On or about December 10, 2007, the NMC will relocate to its permanent address in Martinsburg, WV. Dated: October 4, 2007. Howard L. Hime, Acting Director of Commercial Regulations and Standards, United States Coast Guard. [FR Doc. E7-20493 Filed 10-16-07; 8:45 am] BILLING CODE 4910-15-P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service Construction of a Residential Community in Lake County, FL AGENCY: Fish and Wildlife Service, Interior. ACTION: Notice: Receipt of application for an incidental take permit; request for comments. SUMMARY: We, the Fish and Wildlife Service (Service), announce the availability of an Incidental Take Permit

(ITP)Application and Habitat Conservation Plan (HCP). Founders Ridge, LLC (applicant) requests an ITP for a duration of 10 years under the Endangered Species Act of 1973, as amended (Act). The applicant anticipates taking a total of approximately 32.18 acres of Florida scrub-jay ( *Alphelocoma coerulescens* )—occupied habitat and approximately 1.85 acres of sand skink ( *Neoseps reynoldsi* )—occupied habitat incidental to the construction of a residential development consisting of 963 units and associated amenities, in Lake County, Florida (project). The applicant's HCP describes the mitigation and minimization measures the applicant proposes to address the effects of the project to the Florida scrub-jay and sand skink. DATES: We must receive any written comments on the ITP application and HCP on or before November 16, 2007. ADDRESSES: If you wish to review the application and HCP, you may write the Field Supervisor at our Jacksonville Field Office, 6620 Southpoint Drive South, Suite 310, Jacksonville, FL 32216, or make an appointment to visit during normal business hours. If you wish to comment, you may mail or hand deliver comments to the Jacksonville Field Office, or you may e-mail comments to *paula_sisson@fws.gov.* For more information on reviewing documents and public comments and submitting comments, see SUPPLEMENTARY INFORMATION . FOR FURTHER INFORMATION CONTACT: Paula Sisson, Fish and Wildlife Biologist, Jacksonville Field Office (see ADDRESSES ); telephone: 904/232-2580, ext. 126. SUPPLEMENTARY INFORMATION: Public Availability of Comments Before including your address, phone number, e-mail address, or other personal identifying information in your comment, you should be aware that your entire comment including your personal identifying information may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Please reference permit number TE137074-0 for Founders Ridge, LLC in all requests or comments. Please include your name and return address in your e-mail message. If you do not receive a confirmation from us that we have received your e-mail message, contact us directly at the telephone number listed under FOR FURTHER INFORMATION CONTACT . Background Florida Scrub-Jay The Florida scrub-jay (scrub-jay) is found exclusively in peninsular Florida and is restricted to xeric upland communities (predominately in oak-dominated scrub with open canopies) of the interior and Atlantic coast sand ridges. Increasing urban and agricultural development has resulted in habitat loss and fragmentation, which have adversely affected the distribution and numbers of scrub-jays. Remaining habitat is largely degraded due to the exclusion of fire, which is needed to maintain xeric uplands in conditions suitable for scrub-jays. The total estimated population is between 7,000 and 11,000 individuals. Sand Skink The sand skink is a small fossorial lizard that occurs on the sandy ridges of interior central Florida from Marion County south to Highlands County. Biological information regarding the sand skink is limited due to the secretive nature of the species. Based on the reduction in quality and acreage and the rapid development of xeric upland communities, the sand skink appears to be declining throughout most of its range. By some estimates, as much as 90 percent of the scrub ecosystem has been lost to residential development and conversion to agriculture, primarily citrus groves. Applicant's Proposal The applicant is requesting take of approximately 32.18 acres of occupied Florida scrub-jay habitat and 1.85 acres of occupied sand skink habitat incidental to the construction of a residential community in Lake County, Florida (Parcel # 05-22-26-000200001200 and Parcel # 06-22-26-0001-00009000). The project encompasses about 335.4 acres and currently includes 723 single-family units and 240 multi-family townhomes, a 40-acre community park, various recreational facilities, infrastructure and landscaping. The applicant proposes to mitigate for the take of the Florida scrub-jay at a ratio of 2:1 based on Service Mitigation Guidelines. The applicant will contribute a total of $427,242.00 to the USDA Forest Service to be utilized for scrub-jay conservation pursuant to an MOU between the Service and the Forest Service. Furthermore, to mitigate for impacts to the sand skink, the applicant has proposed to restore, manage and preserve a 4.50-acre area of occupied habitat within the boundaries of the project site. As minimization for impacts to the species, clearing activities during project construction will occur outside the scrub-jay nesting season (March 1-July 15) and the sand skink breeding season (March 1-May 15) to reduce the potential for mortality. We have determined that the applicant's proposal, including the proposed mitigation and minimization measures, would have minor or negligible effects on the species covered in the HCP. Therefore, the ITP is a “low-effect” project and qualifies for categorical exclusions under the National Environmental Policy Act (NEPA), as provided by the Department of the Interior Manual (516 DM 2 Appendix 1 and 516 DM 6 Appendix 1). This preliminary information may be revised based on our review of public comments that we receive in response to this notice. A low-effect HCP is one involving

(1)minor or negligible effects on federally listed or candidate species and their habitats, and

(2)minor or negligible effects on other environmental values or resources. We will evaluate the HCP and comments submitted thereon to determine whether the application meets the requirements of section 10(a) of the Act (16 U.S.C. 1531 *et seq.* ). If we determine that the application meets those requirements, we will issue the ITP for incidental take of the scrub-jay and the sand skink. We will also evaluate whether issuance of the section 10(a)(1)(B) ITP complies with section 7 of the Act by conducting an intra-Service section 7 consultation. We will use the results of this consultation, in combination with the above findings, in the final analysis to determine whether or not to issue the ITP. Authority: We provide this notice under Section 10 of the Act and NEPA regulations (40 CFR 1506.6). Dated: October 9, 2007. David L. Hankla, Field Supervisor, Jacksonville Field Office. [FR Doc. E7-20479 Filed 10-16-07; 8:45 am] BILLING CODE 4310-55-P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service Patoka River National Wildlife Refuge, Pike and Gibson Counties, IN AGENCY: Fish and Wildlife Service, Interior. ACTION: Notice of availability: Draft comprehensive conservation plan and environmental assessment; request for comments. SUMMARY: We, the U.S. Fish and Wildlife Service (Service), announce the availability of a draft comprehensive conservation plan

(CCP)and draft environmental assessment

(EA)for Patoka River National Wildlife Refuge

(NWR)for public review and comment. In this draft CCP/EA, we describe how we propose to manage the refuge for the next 15 years. DATES: To ensure consideration, we must receive your written comments by November 30, 2007. An open house style meeting will be held during the comment period to receive comments and provide information on the draft plan. Special mailings, newspaper articles, internet postings, and other media announcements will inform people of the meetings and opportunities for written comments. ADDRESSES: Send your comments or requests for more information by any of the following methods. You may also drop off comments in person at Patoka River NWR. • *Agency Web site:* View or download a copy of the document and comment at *http://www.fws.gov/midwest/planning/PatokaRiver/* . • *E-mail:* *r3planning@fws.gov* . Include “Patoka River Draft CCP/EA” in the subject line of the message. • *Fax:* 812-749-3059. • *Mail:* Refuge Manager, Patoka River National Wildlife Refuge, 510 1/2 West Morton St., Oakland City, IN 47660. FOR FURTHER INFORMATION CONTACT: Bill McCoy, 812-749-3199. SUPPLEMENTARY INFORMATION: Introduction With this notice, we continue the CCP process for Patoka River NWR, which was started with the notice of intent published in 68 FR 62472 (November 4, 2003). For more about the initial process and the history of this refuge, see that notice. Patoka River NWR, located in southwestern Indiana, includes wetlands and bottomland forest along the Patoka River that provide a variety of habitat for migrant and resident wildlife. The Refuge contains some of the best wood duck production habitat in the State and is used by endangered and threatened species, including the Bald Eagle. The Refuge also includes the Cane Ridge Unit, a 464-acre satellite 24 miles west of the main Refuge that contains nesting habitat for the endangered Interior Least Tern, and the 219-acre White River Bottoms Unit nine miles north of the Refuge. The CCP Process The National Wildlife Refuge System Administration Act of 1966, as amended by the National Wildlife Refuge System Improvement Act of 1997 (16 U.S.C. 668dd-668ee), requires us to develop a comprehensive conservation plan for each national wildlife refuge. The purpose in developing a CCP is to provide refuge managers with a 15-year strategy for achieving refuge purposes and contributing toward the mission of the National Wildlife Refuge System, consistent with sound principles of fish and wildlife management, conservation, legal mandates, and our policies. In addition to outlining broad management direction on conserving wildlife and their habitats, plans identify wildlife-dependent recreational opportunities available to the public, including opportunities for hunting, fishing, wildlife observation, wildlife photography, and environmental education and interpretation. CCP Alternatives and Our Preferred Alternative Priority Issues During the public scoping process, we, other governmental partners, and the public identified several priority issues, which include: Habitat management; water quality within the Patoka River and its tributaries; demand for additional visitor services; land acquisition within the approved Refuge boundary; and declining fish productivity within oxbow lakes. To address these issues, we developed and evaluated the following alternatives during the planning process. Alternative 1, Current Management Under Alternative 1, Current Management, the amount of bottomland forest and managed wetlands would increase and the amount of farmland would decrease; work would continue on improving the water quality within the Patoka River and its tributaries with the long term goal of removal of the streams from the list of impaired waters; there would be some improvements for welcoming and orienting refuge visitors; hunting and fishing opportunities would continue at present levels; wildlife observation opportunities would increase with new or improved facilities at three locations; there would be increased capacity to provide environmental education materials; land acquisition would continue both solely and in conjunction with partners; and there would be no active restoration of oxbow lakes or stream channels. Alternative 2, Passive Management and Reactive Visitor Services Under Alternative 2, bottomland farmland would be allowed to naturally succeed to bottomland forest; work would continue on improving the water quality within the Patoka River and its tributaries with the long term goal of removal of the streams from the list of impaired waters; there would be some improvements for welcoming and orienting refuge visitors; hunting, fishing, and wildlife observation opportunities would continue at present levels but there would be no new facilities for wildlife observation; environmental education would remain at present levels; land acquisition would continue both solely and in conjunction with partners; and there would be no active restoration of oxbow lakes or stream channels. Alternative 3 (Preferred Alternative) Under Alternative 3, the amount of bottomland forest and managed wetlands would increase and the amount of farmland would decrease but some would be retained as stopover habitat for migratory waterbirds; work would continue on improving the water quality within the Patoka River and its tributaries with the long term goal of removal of the streams from the list of impaired waters; there would be some improvements for welcoming and orienting refuge visitors; hunting opportunities would continue at present levels but there would be additional facilities to enhance fishing opportunities; wildlife observation opportunities would increase with new or improved facilities at three locations with the possibility of additional improvements; there would be increased capacity to provide environmental education materials; land acquisition would continue both solely and in conjunction with partners; and information would be collected to help evaluate stream channel and oxbow lake restoration options. Public Meeting We will give the public an opportunity to provide comments at a public meeting. You may obtain the schedule from the addresses listed in this notice (see ADDRESSES ). You may also submit comments anytime during the comment period. Public Availability of Comments Before including your address, phone number, e-mail address, or other personal identifying information in your comment, you should know that your entire comment—including your personal identifying information—may be made publicly available at any time. While you may ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Dated: June 4, 2007. Charles M. Wooley, Acting Regional Director, U.S. Fish and Wildlife Service, Fort Snelling, Minnesota. Editorial Note: This document was received at the Office of the Federal Register on October 12, 2007. [FR Doc. E7-20474 Filed 10-16-07; 8:45 am] BILLING CODE 4310-55-P DEPARTMENT OF THE INTERIOR Bureau of Land Management [AA-6678-L; AK-962-1410-HY-P] Alaska Native Claims Selection AGENCY: Bureau of Land Management, Interior. ACTION: Notice of decision approving lands for conveyance. SUMMARY: As required by 43 CFR 2650.7(d), notice is hereb y given that an appealable decision approving lands for conveyance pursuant to the Alaska Native Claims Settlement Act will be issued to Levelock Natives, Limited. The lands are in the vicinity of Levelock, Alaska, and are located in: Seward Meridian, Alaska, T. 10 S., R. 44 W., Sec. 27. Containing 640 acres. The subsurface estate in these lands will be conveyed to Bristol Bay Native Corporation when the surface estate is conveyed to Levelock Natives, Limited. Notice of the decision will also be published four times in the Bristol Bay Times. DATES: The time limits for filing an appeal are: 1. Any party claiming a property interest which is adversely affected by the decision shall have until November 16, 2007 to file an appeal. 2. Parties receiving service of the decision by certified mail shall have 30 days from the date of receipt to file an appeal. Parties who do not file an appeal in accordance with the requirements of 43 CFR Part 4, Subpart E, shall be deemed to have waived their rights. ADDRESSES: A copy of the decision may be obtained from: Bureau of Land Management, Alaska State Office, 222 West Seventh Avenue, #13, Anchorage, Alaska 99513-7504. FOR FURTHER INFORMATION CONTACT: The Bureau of Land Management by phone at 907-271-5960, or by e-mail at *ak.blm.conveyance@ak.blm.gov* . Persons who use a telecommunication device

(TTD)may call the Federal Information Relay Service

(FIRS)at 1-800-877-8330, 24 hours a day, seven days a week, to contact the Bureau of Land Management. Dina L. Torres, Land Law Examiner, Resolution Branch. [FR Doc. E7-20477 Filed 10-16-07; 8:45 am] BILLING CODE 4310-$$-P DEPARTMENT OF THE INTERIOR Bureau of Land Management [Docket No. CO-200-0777-XZ-241A] Notice of Meeting, Front Range Resource Advisory Council (Colorado) AGENCY: Bureau of Land Management, Interior. ACTION: Notice of public meeting. SUMMARY: In accordance with the Federal Land Policy and Management Act (FLPMA) and the Federal Advisory Committee Act of 1972 (FACA), the U.S. Department of the Interior, Bureau of Land Management

(BLM)Front Range Resource Advisory Council (RAC), will meet as indicated below. DATES: The meeting will be held November 14, 2007 from 9:15 a.m. to 4 p.m. ADDRESSES: Holy Cross Abbey Community Center, 2951 E. Highway 50, Canon City, Colorado 81212. FOR FURTHER INFORMATION CONTACT: Ken Smith,

(719)269-8500. SUPPLEMENTARY INFORMATION: The 15 member Council advises the Secretary of the Interior, through the Bureau of Land Management, on a variety of planning and management issues associated with public land management in the the Royal Gorge Field Office and San Luis Valley, Colorado. Planned agenda topics include: Manager updates on current land management issues including: Presentations and discussions on the Colorado BLM Noxious Weed Program, Greater Arkansas Cooperative Weed Management Program and the South Park Land Tenure Adjustment Plan Amendment. All meetings are open to the public. The public is encouraged to make oral comments to the Council at 9:30 a.m. or written statements may be submitted for the Council's consideration. Depending on the number of persons wishing to comment and time available, the time for individual oral comments may be limited. Summary minutes for the Council Meeting will be maintained in the Royal Gorge Field Office and will be available for public inspection and reproduction during regular business hours within thirty

(30)days following the meeting. Meeting Minutes and agenda (10 days prior to each meeting) are also available at: *http://www.blm.gov/rac/co/frrac/co_fr.htm* . Dated: October 10, 2007. Roy L. Masinton, Royal Gorge Field Manager. [FR Doc. 07-5121 Filed 10-16-07; 8:45 am]

Connectionstraces to 37

Traces to 37 documents

statutes-at-large